<SEC-DOCUMENT>0000950142-20-001360.txt : 20200515
<SEC-HEADER>0000950142-20-001360.hdr.sgml : 20200515
<ACCEPTANCE-DATETIME>20200515081730
ACCESSION NUMBER:		0000950142-20-001360
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20200515
DATE AS OF CHANGE:		20200515
EFFECTIVENESS DATE:		20200515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Childrens Place, Inc.
		CENTRAL INDEX KEY:			0001041859
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-FAMILY CLOTHING STORES [5651]
		IRS NUMBER:				311241495
		FISCAL YEAR END:			0201

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238284
		FILM NUMBER:		20880717

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		2015582400

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHILDRENS PLACE RETAIL STORES INC
		DATE OF NAME CHANGE:	19970702
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>eh2000744_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Paul Weiss
         Document created using EDGARfilings PROfile 6.4.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center; line-height: 1.25; margin-top: 18pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">As filed with the Securities and Exchange Commission on May&#160;15, 2020</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: right;">Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">
        <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center">UNITED STATES<br>
        SECURITIES AND EXCHANGE COMMISSION<br>
        Washington, D.C.&#160; 20549</div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 3pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">____________________</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><font style="font-family: 'Times New Roman', serif; font-size: 14pt;">FORM S-8</font><br>
      REGISTRATION STATEMENT<br>
      UNDER<br>
      THE SECURITIES ACT OF 1933</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 3pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">____________________</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 6pt; font-family: 'Times New Roman', serif; font-size: 18pt; font-weight: bold;">THE CHILDREN&#8217;S PLACE, INC.<br>
      <font style="font-size: 8pt; font-family: 'Times New Roman', Times, serif;">(Exact Name of Registrant as Specified in Its Charter)</font></div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zb450a2111f8a44858351ef3d2146c618" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">31-1241495</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">(State or Other Jurisdiction of</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Incorporation or Organization)</div>
          </td>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">(I.R.S. Employer</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Identification Number)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; margin-bottom: 3pt;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z1f9315de62004025a3e1e7da2d25b177" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">500 Plaza Drive, Secaucus, New Jersey</div>
          </td>
          <td style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">07094</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">(Address of Principal Executive Offices)</div>
          </td>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">(Zip Code)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; margin-bottom: 3pt;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; margin-top: 5pt; margin-bottom: 5pt; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt;">The Children&#8217;s Place, Inc. Fourth Amended and
        Restated 2011 Equity Incentive Plan</font><br>
      (Full title of the plan)</div>
    <div style="text-align: center; line-height: 1.25; margin-top: 5pt; margin-bottom: 5pt; font-family: 'Times New Roman', Times, serif;">____________________</div>
    <div style="text-align: center; line-height: 1.25; margin-top: 5pt; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt; font-variant: small-caps; color: #000000;">Robert A. Karpf, Esq.</font><br>
      <font style="font-size: 10pt;">Senior Vice President, General Counsel and Corporate Secretary</font><br>
      <font style="font-size: 10pt;">The Children's Place,&#160;Inc.</font><br>
      <font style="font-size: 10pt;">500 Plaza Drive</font><br>
      <font style="font-size: 10pt;">Secaucus, New Jersey 07094</font><br>
      <font style="font-size: 10pt;">(201) 558-2400</font><br>
      (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 3pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">____________________</div>
    <div style="text-align: center; text-indent: 4.85pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic; font-weight: bold;">with a copy to:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-variant: small-caps; font-weight: bold;">Lawrence G. Wee, Esq.</div>
    <div style="text-align: center; text-indent: 4.85pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP<br>
      1285 Avenue of the Americas<br>
      New&#160;York, New&#160;York 10019-6064<br>
      (212) 373-3000</div>
    <div style="line-height: 1.25; margin-bottom: 4pt;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 4pt; font-family: 'Times New Roman',Times,serif;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
      reporting company or an emerging growth company.&#160; See the definitions of &#8220;large accelerated filer<font style="font-style: italic;">,</font>&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange
      Act.</div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcdfcd5ce747a48178b2ee1025f9d52e2" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Large accelerated filer</div>
          </td>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#9746;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Accelerated filer</div>
          </td>
          <td colspan="1" style="width: 25%; vertical-align: top;">&#9744;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Non-accelerated filer</div>
          </td>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#9744;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Smaller reporting company</div>
          </td>
          <td colspan="1" style="width: 25%; vertical-align: top;">&#9744;</td>
        </tr>
        <tr>
          <td style="width: 20%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 25%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Emerging growth company</div>
          </td>
          <td colspan="1" style="width: 25%; vertical-align: top;">&#9744;</td>
        </tr>

    </table>
    <div style="line-height: 1.25; margin-top: 5pt; margin-bottom: 5pt; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;"><font style="background-color: #FFFFFF;">If an emerging growth company, indicate by check mark if the registrant has
        elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.</font></div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z224d779ba3a4431fa062e4508c50b521" border="0" cellpadding="2" cellspacing="0">

        <tr>
          <td colspan="5" style="vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-top: 4px double rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Title of each class<br>
              of securities to be registered</div>
          </td>
          <td style="width: 12%; vertical-align: bottom; border-width: 4px 2px 2px; border-style: double solid solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Amount to be<br>
              registered(1)</div>
          </td>
          <td style="width: 17.87%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Proposed maximum<br>
              offering price per share (2)</div>
          </td>
          <td style="width: 21.52%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Proposed maximum<br>
              aggregate offering price(2)</div>
          </td>
          <td style="width: 14.8%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 4px double; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">Amount of registration fee</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">Common Stock, par value $0.10 per share</div>
          </td>
          <td style="width: 12%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">600,000</div>
          </td>
          <td style="width: 17.87%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">$29.17</div>
          </td>
          <td style="width: 21.52%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">$17,502,000.00</div>
          </td>
          <td style="width: 14.8%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">$2,271.76</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za532f328e4514a38a9624c1fb293136e" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 35pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 8pt;">Pursuant to Rule 416(a) under the Securities Act of 1933, shares issuable upon any stock split, stock dividend or similar transaction with respect to the shares
                  covered by this registration statement are also registered hereunder.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze5cb5003b8fb43c1a860ed57471cbd2b" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 35pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 8pt;">Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act and calculated in accordance with Rule 457(h) and
                  Rule 457(c) of the Securities Act, based on the market value of the shares of The Children&#8217;s Place, Inc. (&#8220;The Children&#8217;s Place&#8221;) common stock, as follows:&#160; the product of (i)&#160;$29.17 (the average of the high and low sales prices of The
                  Children&#8217;s Place common stock on the Nasdaq Global Select Market on May 8, 2020) and (ii)&#160;600,000 shares of common stock issuable under the Plan.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EXPLANATORY NOTE</div>
    <div style="text-indent: 20pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">The Children&#8217;s Place, Inc. (the &#8220;Company&#8221;) has prepared this Registration Statement in accordance with the requirements of Form&#160;S&#8209;8
      under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), to register an additional 600,000 shares of its common stock, par value $0.10 per share (the &#8220;common stock&#8221;), that are reserved for issuance in respect of awards to be granted under
      the The Children&#8217;s Place, Inc. Fourth Amended and Restated 2011 Equity Incentive Plan (the &#8220;Plan&#8221;).&#160; Following the registration of these additional shares, we will have registered an aggregate of 3,315,000 shares to be issued under the Plan.&#160; The
      Company previously filed: (i) a Registration Statement on Form&#160;S&#8209;8 on August&#160;30, 2011 to register the 2,000,000 shares of common stock (File&#160;No. 333-176569), initially authorized for issuance under the Plan; and (ii) a Registration Statement on
      Form&#160;S&#8209;8 on June&#160;21, 2016 to register an additional 715,000 shares of common stock (File&#160;No. 333-212158) authorized for issuance under the Plan.&#160; An amendment to increase the number of shares available to be awarded under the Plan from 2,715,000
      shares to 3,315,000 shares was described in the Company&#8217;s definitive proxy statement, filed with the Securities Exchange Commission (the &#8220;Commission&#8221;) on April&#160;3, 2020 and was approved by the Company&#8217;s shareholders on May&#160;14, 2020.&#160; Pursuant to
      General Instruction&#160;E to Form&#160;S&#8209;8, the contents of the Company&#8217;s Form&#160;S&#8209;8 (File&#160;No. 333-176569) and Form S-8 (File No. 333-212158) are incorporated herein by reference except to the extent supplemented, amended or superseded by the information set
      forth herein.&#160; Only those items of Form&#160;S&#8209;8 containing new information not contained in the earlier registration statements are presented herein.</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">PART&#160;II</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Incorporation of
        Documents by Reference.</font></div>
    <div style="text-indent: 20pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">The registrant is subject to the informational and reporting requirements of Sections&#160;13(a), 14 or 15(d) of the Securities Exchange
      Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and in accordance therewith files reports, proxy statements and other information with the Commission.</div>
    <div style="text-indent: 20pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Pursuant to General Instruction&#160;E to Form&#160;S&#8209;8, the contents of our Registration Statements on <a href="http://www.sec.gov/Archives/edgar/data/1041859/000110465911049481/a11-24862_1s8.htm">Form&#160;S&#8209;8</a> (File&#160;No. 333-176569) and <a href="http://www.sec.gov/Archives/edgar/data/1041859/000114420416109181/v442506_s8.htm">Form S-8</a> (File No.
      333-212158) previously filed by us with the Commission on August&#160;30, 2011 and June 21, 2016, respectively, with respect to the shares of common stock to be issued under the Plan are incorporated by reference into this Registration Statement.</div>
    <div style="text-indent: 20pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">We hereby incorporate, or will be deemed to have incorporated, herein by reference the following documents, which are filed with the
      Commission (Exchange Act File No. 000-23071):</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z25ac878cdcbb452387e7211817056f53" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 10.8pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-family: 'Times New Roman', Times, serif;">The Company&#8217;s 2020 Proxy Statement on <a href="http://www.sec.gov/Archives/edgar/data/1041859/000093041320000959/c94016_def14a.htm">Schedule 14A</a> filed with the Commission on
                  April 3, 2020;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8b29b7c59ce24111b8a9ddbb186a3ff4" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 10.8pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-family: 'Times New Roman', Times, serif;">The Company&#8217;s Annual Report on <a href="http://www.sec.gov/Archives/edgar/data/1041859/000162828020003840/plce-212020x10k.htm">Form 10-K</a> for the fiscal year ended February&#160;1,
                  2020 filed with the Commission on March 19, 2020;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div>
        <div style="font-family: 'Times New Roman',Times,serif;">
          <div>
            <table class="DSPFListTable" id="zbef15eb929f347d7ab0ba190dab7f74f" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" cellpadding="0" cellspacing="0">

                <tr style="vertical-align: top;">
                  <td style="width: 36pt;">&#160;</td>
                  <td style="align: right; vertical-align: top; width: 9pt;">
                    <div>&#8226;</div>
                  </td>
                  <td style="align: left; vertical-align: top; width: auto;">
                    <div>The Company&#8217;s Current Reports on Form 8-K filed with the Commission on <a href="http://www.sec.gov/Archives/edgar/data/1041859/000110465920034362/tm2012911d1_8k.htm">March&#160;17, 2020</a>, <a href="http://www.sec.gov/Archives/edgar/data/1041859/000110465920041260/tm2014349-1_8k.htm">March&#160;31, 2020</a>, <a href="http://www.sec.gov/Archives/edgar/data/1041859/000110465920051307/tm2016920d1_8k.htm">April 27, 2020</a> and <a href="http://www.sec.gov/Archives/edgar/data/1041859/000110465920062095/tm2019804-1_8k.htm">May 15, 2020</a>; and</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2e009fb1f367441595a72dbdf1c59fab" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 10.8pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-family: 'Times New Roman', Times, serif;">The description of the Company&#8217;s common stock to be offered hereby which is contained in the registration statement filed on Form 8-A with the Commission on September&#160;18, 1997,
                  under Section 12 of the Exchange Act, including any amendments or reports filed for the purpose of updating such description.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 20pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Each document filed subsequent to the date of this registration statement pursuant to Sections 13(a), 13(c), 14 and 15(d) of the
      Exchange Act (excluding any information furnished pursuant to Item 2.02 and Item 7.01 on any current report on Form 8-K), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which
      deregisters all securities then remaining unsold, shall be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of the filing of such documents.&#160; Any statement contained in a document
      incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which
      also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.&#160; Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration
      Statement.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Exhibits.</font></div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5c6dd23e6de7490e9161a2e5b40cb545" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 10%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Exhibit&#160;Number</div>
            </div>
          </td>
          <td style="width: 2.46%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Description</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.1</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="http://www.sec.gov/Archives/edgar/data/1041859/000114420416107307/v441882_ex3-1.htm">Amended and Restated Certificate of Incorporation of The Children&#8217;s
                Place, Inc. dated May&#160;31, 2016 (incorporated by reference to Exhibit&#160;3.1 of the Company&#8217;s Current Report on Form&#160;8&#8209;K filed with the Commission on June&#160;7, 2016).</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.2</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="http://www.sec.gov/Archives/edgar/data/1041859/000114420416107307/v441882_ex3-2.htm">Sixth Amended and Restated By&#8209;laws of The Children&#8217;s Place, Inc.
                (incorporated by reference to Exhibit 3.2 of the Company&#8217;s Current Report on Form 8-K filed with the Commission on June&#160;7, 2016).</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.3*</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="eh2000744_ex0403.htm">The Children&#8217;s Place, Inc. Fourth Amended and Restated
                2011 Equity Incentive Plan</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">4.4</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="http://www.sec.gov/Archives/edgar/data/1041859/000162828020003840/plce-ex43x212020.htm">Description of The Children&#8217;s Place, Inc. Capital Stock (incorporated
                by reference to Exhibit 4.3 of the Company&#8217;s Annual Report on Form 10-K filed with the Commission on March 19, 2020)</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">5.1*</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="eh2000744_ex0501.htm">Opinion of Paul, Weiss, Rifkind, Wharton &amp; Garrison
                LLP.</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">23.1*</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="eh2000744_ex2301.htm">Consent of Ernst &amp; Young LLP, independent registered
                public accounting firm.</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">23.2*</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="eh2000744_ex0501.htm">Consent of Paul, Weiss, Rifkind, Wharton &amp; Garrison
                LLP (included in the opinion filed as Exhibit&#160;5.1).</a></div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 88%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">24.1*</div>
          </td>
          <td style="width: 2.46%; vertical-align: top;">&#160;</td>
          <td style="width: 88%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><a href="#POWEROFATTORNEY">Power of Attorney (included on signature pages of this Registration Statement).</a></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; margin-bottom: 4pt;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr style="height: 1px; width: 10%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;" align="left" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 2pt;">
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e2f81ad4c7c465da445393a037e8a83" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-style: italic;">*</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-family: 'Times New Roman', Times, serif; font-style: italic;">Filed herewith.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 2pt;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 9.<font style="font-family: 'Times New Roman', serif; font-size: 3pt;">&#160;</font>Undertakings.</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', Times, serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z423484d495d0476aac0686f03bf3e8af" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 36pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(a)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The undersigned registrant hereby undertakes:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zc8b610d78941409e977e00c139ab24f1" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(1)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z91875e83733a40c0aebbc776354220b1" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 63pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(i)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">To include any prospectus required by Section 10(a)(3) of the Securities Act;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z4c50cb24ec834bdfbfa54ac128d6b3c2" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 63pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(ii)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
                recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume
                of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
                filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in
                the effective registration statement;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div>
      <table class="DSPFListTable" id="z82d18f42f2a44129be3e4c8c491ac76b" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 63pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(iii)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">To include any material information with respect to the plan of distribution not previously disclosed in the registration
                statement or any material change to such information in the registration statement;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;"><font style="font-style: italic;">Provided, however,&#160;</font>that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if information required to be
      included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by us pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration
      statement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table class="DSPFListTable" id="zccf5ffc5598443fa90e65f51a750d230" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(2)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">That, for the purpose of determining any liability under the&#160;Securities Act, each such post-effective amendment shall be deemed
                to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zd7c7ca19940a43a0878a5723da4dc6b3" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="width: 36pt;">&#160;</td>
            <td style="vertical-align: top; width: 27pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(3)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
                at the termination of the offering.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="z9ca83f7f6111496f871bfcdc027a9b16" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 36pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(b)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">The registrant hereby undertakes that, for purposes of determining any liability under the&#160;Securities Act, each filing of the
                registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered
                therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div>
      <table class="DSPFListTable" id="zb23fea9ea38a4539b46b4ac93be5bc2f" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" cellpadding="0" cellspacing="0">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 36pt;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">(c)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">Insofar as indemnification for liabilities arising under the&#160;Securities Act&#160;may be permitted to directors, officers and
                controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as
                expressed in the&#160;Securities Act&#160;and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or
                controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in
                the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the&#160;Securities Act&#160;and
                will be governed by the final adjudication of such issue.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; margin-bottom: 2pt;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">SIGNATURES</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets
      all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Secaucus, New Jersey, on May&#160;15, 2020.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zda0100ef541144d59ecb91be5c3526a0" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="3" style="vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">THE CHILDREN&#8217;S PLACE, INC.</div>
          </td>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">By:</div>
          </td>
          <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Jane T. Elfers</div>
          </td>
          <td style="width: 10%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Name:</div>
          </td>
          <td style="width: 25%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Jane T. Elfers</div>
          </td>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 10%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Title:</div>
          </td>
          <td style="width: 25%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chief Executive Officer and President</div>
          </td>
          <td style="width: 10%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a>POWER OF ATTORNEY</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif;">KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned constitutes and appoints Michael Scarpa and Robert A. Karpf or either of them
      his or her true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i)&#160;act on, sign and file with the Securities and
      Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto, (ii)&#160;act on, sign and file such certificates, instruments, agreements and other
      documents as may be necessary or appropriate in connection therewith, (iii)&#160;act on and file any supplement to any prospectus included in this registration statement or any such amendment, and (iv)&#160;take any and all actions which may be necessary or
      appropriate in connection therewith, granting unto such agent, proxy and attorney-in-fact full power and authority to do and perform each and every act and thing necessary or appropriate to be done, as fully for all intents and purposes as he or she
      might or could do in person, hereby approving, ratifying and confirming all that such agents, proxies and attorneys-in-fact or any of their substitutes may lawfully do or cause to be done by virtue thereof.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman', Times, serif;">Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons
        in the capacities and on the dates indicated.</font><br style="line-height: 1.25;">
    </div>
    <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z2949a1fda82541c69d18c14eb0648ba7" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Signature</div>
            </div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Title</div>
            </div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Date</div>
            </div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Norman Matthews</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chairman of the Board</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May 15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Norman Matthews</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Jane T. Elfers</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director, Chief Executive Officer and President</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Jane T. Elfers</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Principal Executive Officer)</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Michael Scarpa</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Chief Operating Officer and Chief Financial Officer</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Michael Scarpa</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Principal Financial Officer)</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Robert Helm</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Senior Vice President, Finance and Inventory Management</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Robert Helm</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(Principal Accounting Officer)</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Joseph Alutto</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Joseph Alutto</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ John E. Bachman</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">John E. Bachman</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Marla Malcolm Beck</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Marla Malcolm Beck</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ <font style="color: #000000;">Elizabeth Boland</font></div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Elizabeth Boland</div>
          </td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Signature</div>
              </div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 38%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Title</div>
              </div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Date</div>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
            <td colspan="1" rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 38%; vertical-align: top;">&#160;</td>
            <td colspan="1" rowspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Joseph Gromek</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Joseph Gromek</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 38%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 38%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Robert Mettler</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Robert Mettler</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 38%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 38%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">/s/ Debby Reiner</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 38%; vertical-align: top; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Director</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">May&#160;15, 2020</div>
            </td>
          </tr>
          <tr>
            <td style="width: 30%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Debby Reiner</div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 38%; vertical-align: top;">&#160;</td>
            <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
            <td style="width: 30%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>eh2000744_ex0403.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Paul Weiss
         Document created using EDGARfilings PROfile 6.4.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div style="text-align: right;"><font style="font-weight: bold;">EXHIBIT 4.3</font><br>
  </div>
  <div><br>
  </div>
  <div>
    <div style="margin: 0px 0px 12pt; line-height: 1.25; font-size: 12pt; font-weight: bold; text-align: center;"> <br>
    </div>
    <div style="margin: 0px 0px 12pt; line-height: 1.25; font-size: 12pt; font-weight: bold; text-align: center;"> <br>
    </div>
    <div style="margin: 0px 0px 12pt; line-height: 1.25; font-size: 12pt; font-weight: bold; text-align: center;">The Children&#8217;s Place, Inc.<font style="font-family: 'Times New Roman',Times,serif;"><br>
      </font>Fourth Amended and Restated<font style="font-family: 'Times New Roman',Times,serif;"><br>
      </font>2011 Equity Incentive Plan</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><br style="line-height: 1.25;">
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-weight: bold;">TABLE OF CONTENTS</div>
    <div style="line-height: 1.25;">
      <table id="z059909878529484f842437fb0cbeac2a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 7%; font-weight: bold; background-color: rgb(198, 244, 249);">1.<br>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Purpose. <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">1 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; font-weight: bold; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; font-weight: bold; background-color: rgb(198, 244, 249);">2.<br>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Definitions.&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">1 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; font-weight: bold; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">3. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Effective Date; Duration. <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">7 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">4. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Administration.&#160;&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">7 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">5. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Grant of Awards; Shares Subject to the Plan; Limitations.&#160;&#160;&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">9 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">6. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Eligibility.&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">10 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">7. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Options.&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">11 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">8. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Stock Appreciation Rights.&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">14 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">9. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Restricted Stock and Restricted Stock Units.&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">16 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">10. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Other Stock-Based Awards. <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">19 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">11. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Performance Compensation Awards.&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">20 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">12. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Changes in Capital Structure and Similar Events.&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">22 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">13. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Effect of Change in Control.&#160;&#160;&#160; <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">24 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">14. <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">Amendments and Termination. <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">24 <br>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 7%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 70%; background-color: rgb(255, 255, 255);">&#160;</td>
            <td rowspan="1" style="width: 5%; background-color: rgb(255, 255, 255);">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">15.&#160; <br>
              </div>
            </td>
            <td style="width: 70%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold;">General. <br>
              </div>
            </td>
            <td style="width: 5%; background-color: rgb(198, 244, 249);">
              <div style="font-weight: bold; text-align: right;">25 <br>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">i</font></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">The Children&#8217;s Place, Inc.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Fourth Amended and Restated<br>
      2011 Equity Incentive Plan</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Purpose.&#160; </font>&#160; The purpose of The Children&#8217;s Place, Inc. Fourth Amended and Restated 2011 Equity Incentive
      Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel, including the services of experienced and knowledgeable non-executive directors, and to provide a means whereby directors, officers,
      employees, consultants and advisors (and prospective directors, officers, employees, consultants and advisors) of the Company and its Affiliates can acquire and maintain an equity interest in the Company, or be paid incentive compensation, including
      but not limited to incentive compensation measured by reference to the value of Common Stock or the results of operations of the Company, thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning their
      interests with those of the Company&#8217;s shareholders.&#160; This Plan document is an omnibus document which includes, in addition to the Plan, separate sub-plans (&#8220;<u>Sub Plans</u>&#8221;) that permit offerings of grants to employees of certain Designated Foreign
      Subsidiaries.&#160; Offerings under the Sub Plans may be made in particular locations outside the United States of America and shall comply with local laws applicable to offerings in such foreign jurisdictions.&#160; The Plan shall be a separate and
      independent plan from the Sub Plans, but the total number of shares of Common Stock authorized to be issued under the Plan applies in the aggregate to both the Plan and the Sub Plans.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Definitions.&#160; &#160; </font>&#160; The following definitions shall be applicable throughout the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Affiliate</u>&#8221; means (i) any person or entity that directly or indirectly controls, is controlled by or is under common control with the Company and/or (ii) to the
      extent provided by the Committee, any person or entity in which the Company has a significant interest.&#160; The term &#8220;control&#8221; (including, with correlative meaning, the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as applied to any person or
      entity, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person or entity, whether through the ownership of voting or other securities, by contract or otherwise.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Award</u>&#8221; means, individually or collectively, any Incentive Stock Option, Nonqualified Stock Option, Stock Appreciation Right, Restricted Stock, Restricted Stock
      Unit, Other Stock-Based Award and Performance Compensation Award granted under the Plan.&#160; For purposes of Section 5(c) of the Plan, &#8220;Award&#8221; and &#8220;Award under the Plan&#8221; shall also mean any stock-based Award granted under a Prior Plan and outstanding on
      the Effective Date.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Beneficial Owner</u>&#8221; has the meaning set forth in Rule 13d-3 promulgated under Section&#160;13 of the Exchange Act.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Board</u>&#8221; means the Board of Directors of the Company.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Cause</u>&#8221; means, in the case of a particular Award, unless the applicable Award agreement states otherwise, (i)&#160;the Company or an Affiliate having &#8220;cause&#8221; to
      terminate a Participant&#8217;s employment or service, as defined in any employment, consulting, change in control, severance or any other agreement between the Participant and the Company or an Affiliate&#160; in effect at the time of such termination or
      (ii)&#160;in the absence of any such employment, consulting, change in control, severance or other agreement (or the absence of any definition of &#8220;cause&#8221; or term of similar import therein), (A) the Participant has failed to reasonably perform his or her
      duties to the Company, or has failed to follow the lawful instructions of the Board or his or her direct superiors, in each case, other than as a result of his or her incapacity due to physical or mental illness or injury, and such failure has
      resulted in, or could reasonably be expected to </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">result in, harm (whether financially, reputationally or otherwise) to the Company or an Affiliate, (B)&#160;the Participant has engaged in conduct
        harmful (whether financially, reputationally or otherwise) to the Company or an Affiliate, (C)&#160;the Participant having been convicted of, or plead guilty or no contest to, a felony or any crime involving as a material element fraud or dishonesty or
        moral turpitude, (D)&#160;the willful misconduct or gross neglect of the Participant that has resulted in or could reasonably be expected to result in harm (whether financially, reputationally or otherwise) to the Company or an Affiliate, (E) the
        willful violation by the Participant of the written policies of the Company or any of its Affiliates, that that has resulted in or could reasonably be expected to result in harm (whether financially, reputationally or otherwise) to the Company or
        an Affiliate, (F) the Participant&#8217;s fraud or misappropriation, embezzlement or misuse of funds or property belonging to the Company (other than good faith expense account disputes), (G) the Participant&#8217;s act of personal dishonesty which involves
        personal profit in connection with the Participant&#8217;s employment or service with the Company or an Affiliate, (H) the willful breach by the Participant of fiduciary duty owed to the Company or an Affiliate, or (I)&#160;in the case of a Participant who is
        a Non-Employee Director, the Participant engaging in any of the activities described in clauses (A)&#160;through (H)&#160;above; <u>provided</u>, <u>however</u>, that the Participant shall be provided a 10-day period to cure any of the events or
        occurrences described in the immediately preceding clause (A) hereof, to the extent capable of cure during such 10-day period.&#160; Any determination of whether Cause exists shall be made by the Committee in its sole discretion.</font></div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9060812915174fcfb646b956f67c0802" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 57pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">(f)</td>
              <td style="width: auto; vertical-align: top;">
                <div>&#8220;<u>Change in Control</u>&#8221; shall, in the case of a particular Award, be deemed to occur upon:</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-indent: 31.5pt; margin-left: 58.5pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the acquisition by any individual, entity or group (within the meaning of Section&#160;13(d)(3) or 14(d)(2) of the Exchange Act (a &#8220;<u>Person</u>&#8221;))
      of beneficial ownership (within the meaning of Rule&#160;13d&#8209;3 promulgated under the Exchange Act) of&#160; more than 50% (on a fully diluted basis) of either (A)&#160;the then outstanding shares of Common Stock taking into account as outstanding for this purpose
      such Common Stock issuable upon the exercise of options or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such Common Stock (the &#8220;<u>Outstanding Company Common Stock</u>&#8221;) or (B)&#160;the combined
      voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;<u>Outstanding Company Voting Securities</u>&#8221;); <u>provided</u>, <u>however</u>, that for purposes of this Plan, the
      following acquisitions shall not constitute a Change in Control:&#160; (I)&#160;any acquisition by the Company, or (II)&#160;any acquisition by any employee benefit plan sponsored or maintained by the Company;</div>
    <div style="text-indent: 31.5pt; margin-left: 58.5pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; individuals who, during any consecutive 12-month period, constitute the Board (the &#8220;<u>Incumbent Directors</u>&#8221;) cease for any reason to
      constitute at least a majority of the Board, <u>provided</u>, that any person becoming a director subsequent to the date hereof, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then
      on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination) shall be an Incumbent Director; <u>provided</u>, <u>however</u>,
      that no individual initially elected or nominated as a director of the Company as a result of an actual or threatened election contest, as such terms are used in Rule&#160;14a-12 of Regulation&#160;14A promulgated under the Exchange Act, with respect to
      directors or as a result of any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed to be an Incumbent Director;</div>
    <div style="text-indent: 31.5pt; margin-left: 58.5pt; line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman',Times,serif;">the approval by the
        shareholders of the Company of a plan of complete dissolution or liquidation of the Company; or<br>
        <br>
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 31.5pt; margin-left: 58.5pt; line-height: 1.25; margin-bottom: 12pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the consummation of a reorganization, recapitalization, merger, consolidation, statutory share exchange or similar form of corporate transaction
      involving the Company (a &#8220;<u>Business Combination</u>&#8221;), or sale, transfer or other disposition of all or substantially all of the business or assets of the Company to an entity that is not an Affiliate of the Company (a &#8220;<u>Sale</u>&#8221;), that in each
      case requires the approval of the Company&#8217;s stockholders (whether for such Business Combination or Sale or the issuance of securities in such Business Combination or Sale), unless immediately following such Business Combination or Sale:&#160; (A) more
      than 50% of the total voting power of (x) the entity resulting from such Business Combination or the entity which has acquired all or substantially all of the business or assets of the Company in a Sale (in either case, the &#8220;<u>Surviving Company</u>&#8221;),


      or (y) if applicable, the ultimate parent entity that directly or indirectly has beneficial ownership of sufficient voting securities eligible to elect a majority of the board of directors (or the analogous governing body) of the Surviving Company
      (the &#8220;<u>Parent Company</u>&#8221;), is represented by the Outstanding Company Voting Securities that were outstanding immediately prior to such Business Combination or Sale (or, if applicable, is represented by shares into which the Outstanding Company
      Voting Securities were converted pursuant to such Business Combination or Sale), and such voting power among the holders thereof is in substantially the same proportion as the voting power of the Outstanding Company Voting Securities among the
      holders thereof immediately prior to the Business Combination or Sale, (B) no Person (other than any employee benefit plan sponsored or maintained by the Surviving Company or the Parent Company), is or becomes the beneficial owner, directly or
      indirectly, of more than 50% of the total voting power of the outstanding voting securities eligible to elect members of the board of directors (or the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving
      Company) and (C) at least a majority of the members of the board of directors (or the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving Company) following the consummation of the Business Combination or
      Sale were Board members at the time of the Board&#8217;s approval of the execution of the initial agreement providing for such Business Combination or Sale.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986, as amended, and any successor thereto.&#160; Reference in the Plan to any section of the Code shall be deemed to
      include any regulations or other interpretative guidance under such section, and any amendments or successor provisions to such section, regulations or guidance.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Committee</u>&#8221; means the Compensation Committee of the Board or subcommittee thereof if required with respect to actions taken to obtain the exception for
      performance-based compensation under Section&#160;162(m) of the Code or to comply with Rule 16b-3 of the Exchange Act in respect of Awards or, if no such Compensation Committee or subcommittee thereof exists, the Board.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; &#8220;<u>Common Stock</u>&#8221; means the common stock, par value $0.10 per share, of the Company (and any stock or other securities into which such common stock may be
      converted or into which it may be exchanged).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(j)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; &#8220;<u>Company</u>&#8221; means The Children&#8217;s Place, Inc., a Delaware corporation, and<font style="font-weight: bold;">&#160;</font>any successor thereto.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Designated Foreign Subsidiaries</u>&#8221; means all Affiliates organized under the laws of any jurisdiction or country other than the United States of America that may
      be designated by the Board or the Committee from time to time.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(l)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;<u>Disability</u>&#8221; means, unless in the case of a particular Award the applicable Award agreement states otherwise, the Company or an Affiliate having cause to
      terminate a Participant&#8217;s employment or service on account of &#8220;disability,&#8221; as defined in any then-existing employment, consulting, change in control, severance or other agreement between the Participant and the Company or an Affiliate or, in the
      absence of such an employment, consulting, change in control, severance or other agreement (or in the absence of any definition of &#8220;disability&#8221; or term of similar import therein), a Participant&#8217;s total disability as defined below and (to the extent
      required by Code Section 409A) determined in a manner consistent with Code Section 409A and the regulations thereunder:</div>
    <div style="text-indent: 22.5pt; margin-left: 58.5pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment
      that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months.</div>
    <div style="text-indent: 22.5pt; margin-left: 58.5pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A Participant will be deemed to have suffered a Disability if determined to be totally disabled by the Social Security Administration.&#160; In
      addition, the Participant will be deemed to have suffered a Disability if determined to be disabled in accordance with a disability insurance program maintained by the Company.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Effective Date</u>&#8221; means the date of the annual shareholder meeting at which the Plan is approved by the shareholders.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Eligible Director</u>&#8221; means a person who is (i)&#160;a &#8220;non&#8209;employee director&#8221; within the meaning of Rule&#160;16b&#8209;3 under the Exchange Act and (ii)&#160;an &#8220;outside director&#8221;
      within the meaning of Section&#160;162(m) of the Code and (iii) an &#8220;independent director&#8221; under the rules of the NASDAQ or any other securities exchange or inter-dealer quotation system on which the Common Stock is listed or quoted, or a person meeting
      any similar requirement under any successor rule or regulation.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Eligible Person</u>&#8221; means any (i)&#160;individual employed by the Company or an Affiliate who satisfies all of the requirements of Section&#160;6 of the Plan; <u>provided</u>,
      <u>however</u>, that no such employee covered by a collective bargaining agreement shall be an Eligible Person unless and to the extent that such eligibility is set forth in such collective bargaining agreement or in an agreement or instrument
      relating thereto; (ii)&#160;director or officer of the Company or an Affiliate; (iii)&#160;consultant or advisor to the Company or an Affiliate who may be offered securities registrable on Form&#160;S&#8209;8 under the Securities Act; or (iv) any prospective employees,
      directors, officers, consultants or advisors who have accepted offers of employment or consultancy from the Company or its Affiliates (and would satisfy the provisions of clauses (i) through (iii) above once he or she begins employment with or
      providing services to the Company or its Affiliates).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and any successor thereto.&#160; Reference in the Plan to any section of (or rule promulgated
      under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or guidance.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Exercise Price</u>&#8221; has the meaning given such term in Section&#160;7(b) of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(r)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; &#8220;<u>Fair Market Value</u>&#8221; means, on a given date, (i)&#160;if the Common Stock is listed on a national securities exchange, the closing sales price of the Common Stock
      reported on the primary exchange on which the Common Stock is listed and traded on such date, or, if there is no such sale on that date, then on the last preceding date on which such a sale was reported; (ii)&#160;if the Common Stock is not listed on any
      national securities exchange but is quoted in an inter-dealer quotation service on a last sale basis, the average between the closing bid price and ask price reported on such date, or, if there is no such </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">sale on that date, then on the last preceding date on which a sale was reported; (iii) if Fair Market Value cannot be determined under clause
        (i) or (ii) above, or if the Committee determines in its sole discretion that the shares of Common Stock are too thinly traded for Fair Market Value to be determined pursuant to clause (i) or (ii), the fair market value as determined in good faith
        by the Committee in its sole discretion; or (iv)&#160;if the Common Stock is not listed on a national securities exchange or quoted in an inter-dealer quotation service on a last sale basis, the amount determined by the Committee in good faith to be the
        fair market value of the Common Stock.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(s)&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160; &#8220;<u>Good Reason</u>&#8221; shall mean the occurrence of any of the following without the Participant&#8217;s prior written consent:&#160; (i) a material reduction in the Participant&#8217;s
      then current base salary or target bonus percentage, (ii) a material diminution of the Participant&#8217;s duties or responsibilities, (iii) the assignment to the Participant of duties or responsibilities which are materially inconsistent with the
      Participant&#8217;s previous duties or responsibilities, or (iv) relocation of the Participant&#8217;s principal work location to a location more than thirty (30) miles from the Participant&#8217;s previous principal work location; provided, however, that no such
      occurrence shall constitute Good Reason unless the Participant provides the Company with written notice of the matter within thirty (30) days after the Participant first has knowledge of the matter and, in the case of clauses (i), (ii) or (iii)
      hereof, the Company fails to cure such matter within ten (10) days after its receipt of such notice.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(t)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; &#8220;<u>Immediate Family Members</u>&#8221; shall have the meaning set forth in Section&#160;15(b).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Incentive Stock Option</u>&#8221; means an Option which is designated by the Committee as an incentive stock option as described in Section&#160;422 of the Code and otherwise
      meets the requirements set forth in the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Indemnifiable Person</u>&#8221; shall have the meaning set forth in Section 4(f) of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Involuntary Termination</u>&#8221; shall mean (i) the involuntary termination of the Participant&#8217;s employment with Company or any of its subsidiaries (other than for
      Cause, death or Disability) or (ii) the Participant&#8217;s resignation of employment with Company or any of its subsidiaries for Good Reason.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(x)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;<u>NASDAQ</u>&#8221; means the NASDAQ Stock Market.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(y)&#160;&#160;&#160; &#160; &#160;&#160;&#160; &#8220;<u>Negative Discretion</u>&#8221; shall mean the discretion authorized by the Plan to be applied by the Committee to eliminate or reduce the size of a Performance
      Compensation Award consistent with Section&#160;162(m) of the Code.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(z)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Nonqualified Stock Option</u>&#8221; means an Option which is not designated by the Committee as an Incentive Stock Option.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Non-Employee Director</u>&#8221; means a member of the Board who is not an employee of the Company or any Affiliate.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Option</u>&#8221; means an Award granted under Section&#160;7 of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Option Period</u>&#8221; has the meaning given such term in Section&#160;7(c) of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Other Stock-Based Award</u>&#8221; means an Award granted under Section&#160;10 of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Participant</u>&#8221; means an Eligible Person who has been selected by the Committee to participate in the Plan and to receive an Award pursuant to Section&#160;6 of the
      Plan.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Performance Compensation Award</u>&#8221; shall mean any Award designated by the Committee as a Performance Compensation Award pursuant to Section&#160;11 of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Performance Criteria</u>&#8221; shall mean the criterion or criteria that the Committee shall select for purposes of establishing the Performance Goal(s) for a
      Performance Period with respect to any Performance Compensation Award under the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Performance Formula</u>&#8221; shall mean, for a Performance Period, the one or more objective formulae applied against the relevant Performance Goal to determine, with
      regard to the Performance Compensation Award of a particular Participant, whether all, some portion but less than all, or none of the Performance Compensation Award has been earned for the Performance Period.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;<u>Performance Goals</u>&#8221; shall mean, for a Performance Period, the one or more goals established by the Committee for the Performance Period based upon the
      Performance Criteria.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(jj)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;<u>Performance Period</u>&#8221; shall mean the one or more periods of time of not less than 12 months, as the Committee may select, over which the attainment of one or
      more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to, and the payment of, a Performance Compensation Award.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Permitted Transferee</u>&#8221; shall have the meaning set forth in Section&#160;15(b) of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ll)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#8220;<u>Person</u>&#8221; has the meaning given in Section&#160;3(a)(9) of the Exchange Act, as modified and used in Sections&#160;13(d) and 14(d) thereof, except that such term shall
      not include (i)&#160;the Company or any of its subsidiaries, (ii)&#160;a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its Affiliates, (iii)&#160;an underwriter temporarily holding securities pursuant to an
      offering of such securities, or (iv)&#160;a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of Common Stock of the Company.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(mm)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Plan</u>&#8221; means this The Children&#8217;s Place, Inc. 2011 Equity Incentive Plan, as amended.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(nn) &#160; &#160;&#160;&#160;&#160;&#160; &#8220;<u>Prior Plan</u>&#8221; shall mean, as amended from time to time, each of the Amended and Restated 2005 Equity Incentive Plan of The Children&#8217;s Place Retail Stores, Inc.
      and the 1997 Stock Option Plan of The Children&#8217;s Place Retail Stores, Inc.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(oo)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Released Unit</u>&#8221; shall have the meaning assigned to it in Section 9(e).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Restricted Period</u>&#8221; means the period of time determined by the Committee during which an Award or a portion thereof&#160; is subject to restrictions or, as
      applicable, the period of time within which performance is measured for purposes of determining whether an Award has been earned.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(qq)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Restricted Stock</u>&#8221; means Common Stock, subject to certain specified restrictions (including, without limitation, a requirement that the Participant remain
      continuously employed or provide continuous services for a specified period of time), granted under Section 9 of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(rr)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#8220;<u>Restricted Stock Unit</u>&#8221; means an unfunded and unsecured promise to deliver shares of Common Stock, cash, other securities or other property, subject to
      certain restrictions (including, without limitation, a requirement that the Participant remain continuously employed or provide continuous services for a specified period of time), granted under Section 9 of the Plan.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ss)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Retirement</u>&#8221; means a voluntary termination of employment or service with the Company and all Affiliates by a Participant on or after the Participant&#8217;s
      Retirement Age (other than any such termination effective on or after any time that the Company has grounds to terminate the Participant&#8217;s employment or service for Cause (assuming for such purpose that no cure period were available)).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(tt)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Retirement Age</u>&#8221; means, unless determined otherwise by the Committee, attainment of age 65.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(uu)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>SAR Period</u>&#8221; has the meaning given such term in Section&#160;8(c) of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(vv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and any successor thereto.&#160; Reference in the Plan to any section of (or rule promulgated under)
      the Securities Act shall be deemed to include any rules, regulations or other interpretative guidance under such section or rule, and any amendments or successor provisions to such section, rules, regulations or guidance.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ww)&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Stock Appreciation Right</u>&#8221; or &#8220;<u>SAR</u>&#8221; means an Award granted under Section&#160;8 of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(xx)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Strike Price</u>&#8221; has the meaning given such term in Section 8(b) of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(yy)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<u>Substitute Award</u>&#8221; has the meaning given such term in Section 5(e).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(zz)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#8220;<u>Sub Plans</u>&#8221; has the meaning given such term in Section 1.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Effective Date; Duration.&#160; </font>&#160; The Plan shall be effective as of the Effective Date.&#160; The expiration date of
      the Plan, on and after which date no Awards may be granted hereunder, shall be the tenth anniversary of the Effective Date; <u>provided</u>, <u>however</u>, that such expiration shall not affect Awards then outstanding, and the terms and conditions
      of the Plan shall continue to apply to such Awards.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Administration.&#160; </font>&#160; (a)&#160; The Committee shall administer the Plan.&#160; The majority of the members of the
      Committee shall constitute a quorum.&#160; The acts of a majority of the members present at any meeting at which a quorum is present or acts approved in writing by a majority of the Committee shall be deemed the acts of the Committee. To the extent
      required to comply with the provisions of Rule 16b-3 promulgated under the Exchange Act (if the Board is not acting as the Committee under the Plan) or necessary to obtain the exception for performance-based compensation under Section 162(m) of the
      Code, or any exception or exemption under the rules of the NASDAQ or any other securities exchange or inter-dealer quotation system on which the Common Stock is listed or quoted, as applicable, it is intended that each member of the Committee shall,
      at the time he or she takes any action with respect to an Award under the Plan, be an Eligible Director.&#160; However, the fact that a Committee member shall fail to qualify as an Eligible Director shall not invalidate any Award granted or action taken
      by the Committee that is otherwise validly granted or taken under the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; Subject to the provisions of the Plan and applicable law, the Committee shall have the sole and plenary authority, in addition to other express powers and
      authorizations conferred on the Committee by the Plan, to:&#160; (i)&#160;designate Participants; (ii)&#160;determine the type or types of Awards to be granted to a Participant; (iii)&#160;determine the number of shares of Common Stock to be covered by, or with respect
      to which payments, rights, or other matters are to be calculated in connection with, Awards; (iv)&#160;determine the terms and conditions of any Award; (v) determine whether, to what extent, and under what circumstances Awards may be settled or exercised
      in cash, shares of Common Stock, other securities, other Awards or other property, or canceled, forfeited, or suspended and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or suspended; (vi)&#160;determine </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="font-family: 'Times New Roman', Times, serif; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      whether, to what extent, and under what circumstances the delivery of cash, Common Stock, other securities, other Awards or other property and other amounts payable with respect to an Award shall be deferred either automatically or at the election of
      the Participant or of the Committee; (vii)&#160;interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Award granted under, the Plan;
      (viii)&#160;establish, amend, suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper administration of the Plan; (ix) accelerate the vesting, delivery or exercisability of, payment for or
      lapse of restrictions on, or waive any condition in respect of, Awards; and (x)&#160;make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; Except to the extent prohibited by applicable law or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which the
      Common Stock is listed or quoted, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers to any person or persons selected
      by it.&#160; Any such allocation or delegation may be revoked by the Committee at any time.&#160; Without limiting the generality of the foregoing, the Committee may delegate to one or more officers of the Company or any Affiliate the authority to act on
      behalf of the Committee with respect to any matter, right, obligation, or election which is the responsibility of or which is allocated to the Committee herein, and which may be so delegated as a matter of law, except for grants of Awards to persons
      (i) who are non-employee members of the Board or otherwise are subject to Section&#160;16 of the Exchange Act or (ii)&#160;who are, or who are reasonably expected to be, &#8220;covered employees&#8221; for purposes of Section&#160;162(m) of the Code.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; The Committee shall have the authority to amend the Plan (including by the adoption of appendices or subplans) and/or the terms and conditions relating to an Award to
      the extent necessary to permit participation in the Plan by Eligible Persons who are located outside of the United States on terms and conditions comparable to those afforded to Eligible Persons located within the United States; <u>provided</u>, <u>however</u>,
      that no such action shall be taken without shareholder approval if such approval is necessary to comply with any tax or regulatory requirement applicable to the Plan (including as necessary to prevent the Company from being denied a tax deduction on
      account of Section 162(m) of the Code).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e) &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160; Unless otherwise expressly provided in the Plan, all designations, determinations, interpretations, and other decisions under or with respect to the Plan or any Award
      or any documents evidencing Awards granted pursuant to the Plan shall be within the sole discretion of the Committee, may be made at any time and shall be final, conclusive and binding upon all persons or entities, including, without limitation, the
      Company, any Affiliate, any Participant, any holder or beneficiary of any Award, and any shareholder of the Company.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(f)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; No member of the Board, the Committee or any employee or agent of the Company (each such person, an &#8220;<u>Indemnifiable Person</u>&#8221;) shall be liable for any action
      taken or omitted to be taken or any determination made with respect to the Plan or any Award hereunder (unless constituting fraud or a willful criminal act or omission).&#160; Each Indemnifiable Person shall be indemnified and held harmless by the Company
      against and from any loss, cost, liability, or expense (including attorneys&#8217; fees) that may be imposed upon or incurred by such Indemnifiable Person in connection with or resulting from any action, suit or proceeding to which such Indemnifiable
      Person may be a party or in which such Indemnifiable Person may be involved by reason of any action taken or omitted to be taken or determination made under the Plan or any Award agreement and against and from any and all amounts paid by such
      Indemnifiable Person with the Company&#8217;s approval (not to be unreasonably withheld), in settlement thereof, or paid by such Indemnifiable Person in satisfaction of any judgment in any such action, suit or proceeding against such Indemnifiable Person,
      and the Company shall advance to such Indemnifiable Person any such </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">expenses promptly upon written request (which request shall include an undertaking by the Indemnifiable Person to repay the amount of such
        advance if it shall ultimately be determined as provided below that the Indemnifiable Person is not entitled to be indemnified); provided that the Company shall have the right, at its own expense, to assume and defend any such action, suit or
        proceeding and once the Company gives notice of its intent to assume the defense, the Company shall have sole control over such defense with counsel of recognized standing of the Company&#8217;s choice.&#160; The foregoing right of indemnification shall not
        be available to an Indemnifiable Person to the extent that a final judgment or other final adjudication (in either case not subject to further appeal) binding upon such Indemnifiable Person determines that the acts or omissions or determinations of
        such Indemnifiable Person giving rise to the indemnification claim resulted from such Indemnifiable Person&#8217;s fraud or willful criminal act or omission or that such right of indemnification is otherwise prohibited by law or by the Company&#8217;s
        Certificate of Incorporation or Bylaws.&#160; The foregoing right of indemnification shall not be exclusive of or otherwise supersede any other rights of indemnification to which such Indemnifiable Persons may be entitled under the Company&#8217;s Certificate
        of Incorporation or Bylaws, as a matter of law, individual indemnification agreement or contract or otherwise, or any other power that the Company may have to indemnify such Indemnifiable Persons or hold them harmless.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in the Plan, the Board may, in its sole discretion, at any time and from time to time, grant Awards and administer
      the Plan with respect to such Awards.&#160; Any such actions by the Board shall be subject to the applicable rules of the NASDAQ or any other securities exchange or inter-dealer quotation system on which the Common Stock is listed or quoted.&#160; In any such
      case, the Board shall have all the authority granted to the Committee under the Plan.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Grant of Awards; Shares Subject to the Plan; Limitations.</font>&#160; (a) The Committee may, from time to time, grant
      Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Other Stock-Based Awards and/or Performance Compensation Awards to one or more Eligible Persons.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; Awards granted under the Plan shall be subject to the following limitations:&#160; (i)&#160;subject to Section&#160;12 of the Plan and subsection (e) below, no more than 3,315,000
      shares of Common Stock may be delivered in the aggregate pursuant to Awards granted under the Plan; (ii) subject to Section&#160;12 of the Plan, no more than 750,000 shares of Common Stock may be subject to grants of Options or SARs under the Plan to any
      single Participant during any calendar year; (iii) subject to Section&#160;12 of the Plan, no more than 2,000,000 shares of Common Stock may be delivered pursuant to the exercise of Incentive Stock Options granted under the Plan; (iv) subject to
      Section&#160;12 of the Plan, no more than 750,000 shares of Common Stock may be delivered in respect of Performance Compensation Awards denominated in shares of Common Stock granted pursuant to Section&#160;11 of the Plan to any Participant for a single
      Performance Period (or with respect to each single fiscal year in the event a Performance Period extends beyond a single fiscal year), or in the event such Performance Compensation Award is paid in cash, other securities, other Awards or other
      property, no more than the Fair Market Value of 750,000 shares of Common Stock on the last day of the Performance Period to which such Award relates; and (v) the maximum amount that can be paid to any individual Participant for a single fiscal year
      during a Performance Period (or with respect to each single year in the event a Performance Period extends beyond a single year) pursuant to a Performance Award denominated in cash described in Section&#160;11(a) of the Plan shall be $10,000,000.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; Shares of Common Stock shall be deemed to have been used in settlement of Awards whether or not they are actually delivered or the Fair Market Value equivalent of
      such shares is paid in cash; <u>provided</u>, <u>however</u>, that if shares of Common Stock issued upon exercise, vesting or settlement of an Award (other than an Option or a SAR), or shares of Common Stock owned by a Participant, are surrendered
      or tendered to the Company (either directly or by means of attestation) in payment of any taxes required to be withheld in respect of an Award, in each case, in accordance with the terms and </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">conditions of the Plan and any applicable Award agreement, such surrendered or tendered shares shall again become available for other Awards
        under the Plan; <u>provided</u>, <u>further</u>, that in no event shall such shares increase the number of shares of Common Stock that may be delivered pursuant to Incentive Stock Options granted under the Plan.&#160; In accordance with (and without
        limitation upon) the preceding sentence, if and to the extent all or any portion of an Award under the Plan expires, terminates or is canceled or forfeited for any reason whatsoever without the Participant having received any benefit therefrom, the
        shares covered by such Award or portion thereof shall again become available for other Awards under the Plan.&#160; For purposes of the foregoing sentence, a Participant shall not be deemed to have received any &#8220;benefit&#8221; (i) in the case of forfeited
        Restricted Stock by reason of having enjoyed voting rights and dividend rights prior to the date of forfeiture or (ii) in the case of an Award canceled by reason of a new Award being granted in substitution therefor.&#160; Notwithstanding anything to
        the contrary contained herein, for purposes of clarity: (1)&#160;any shares of Common Stock that are tendered (by attestation or otherwise) or exchanged by a Participant or withheld by the Company (by net exercise or other means) as full or partial
        payment of the exercise price of any Option or SAR shall not be available for subsequent Awards under the Plan; (2)&#160;shares of Common Stock exchanged by a Participant or withheld by the Company or any Affiliate to satisfy the tax withholding or tax
        payment obligations related to any Option or SAR shall not be available for subsequent Awards under the Plan; (3)&#160;shares of Common Stock that are purchased or repurchased by the Company with Option proceeds shall not be available for subsequent
        Awards under the Plan; and (4)&#160;all shares of Common Stock covered by an SAR, to the extent that it is exercised and settled in shares of Common Stock, and whether or not shares of Common Stock are actually issued to the Participant upon exercise of
        the SAR, shall be considered issued or transferred pursuant to the Plan.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; Shares of Common Stock delivered by the Company in settlement of Awards may be authorized and unissued shares, shares held in the treasury of the Company, shares
      purchased on the open market or by private purchase, or a combination of the foregoing.&#160; Following the Effective Date, no further Awards shall be granted under any Prior Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding Awards previously granted by the
      Company or any Affiliate or an entity directly or indirectly acquired by the Company or with which the Company combines (&#8220;<u>Substitute Awards</u>&#8221;).&#160; The number of shares of Common Stock underlying any Substitute Awards shall be counted against the
      aggregate number of shares of Common Stock available for Awards under the Plan; <u>provided</u>, <u>however</u>, that Substitute Awards issued in connection with the assumption of, or the substitution for, outstanding Awards previously granted by
      the Company of an Affiliate or by an entity that is acquired by the Company or any Affiliate through a merger or acquisition shall not be counted against the aggregate number of shares of Common Stock available for Awards under the Plan; <u>provided</u>,
      <u>further</u>, that Substitute Awards issued in connection with the assumption of, or in substitution for, outstanding options intended to qualify as &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code that were previously
      granted by an entity that is acquired by the Company or any Affiliate through a merger or acquisition shall be counted against the aggregate number of shares of Common Stock available for Awards of Incentive Stock Options under the Plan.&#160; Subject to
      applicable stock exchange requirements, available shares under a stockholder approved plan of an entity directly or indirectly acquired by the Company or with which the Company combines (as appropriately adjusted to reflect the acquisition or
      combination transaction) may be used for Awards under the Plan and shall not reduce the number of shares of Common Stock available for delivery under the Plan.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Eligibility.&#160; </font>&#160; Participation shall be limited to Eligible Persons who have entered into an Award
      agreement or who have received written notification from the Committee, or from a person designated by the Committee, that they have been selected to participate in the Plan.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Options.&#160; </font>&#160; (a)&#160; <u>Generally</u>.&#160; Each Option granted under the Plan shall be evidenced by an Award
      agreement.&#160; Each Option so granted shall be subject to the conditions set forth in this Section&#160;7, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award agreement.&#160; All Options granted under the Plan
      shall be Nonqualified Stock Options unless the applicable Award agreement expressly states that the Option is intended to be an Incentive Stock Option.&#160; Incentive Stock Options shall be granted only to Eligible Persons who are employees of the
      Company and its Affiliates, and no Incentive Stock Option shall be granted to any Eligible Person who is ineligible to receive an Incentive Stock Option under the Code.&#160; No Option shall be treated as an Incentive Stock Option unless the Plan has been
      approved by the shareholders of the Company in a manner intended to comply with the shareholder approval requirements of Section&#160;422(b)(1)&#160;of the Code, provided that any Option intended to be an Incentive Stock Option shall not fail to be effective
      solely on account of a failure to obtain such approval, but rather such Option shall be treated as a Nonqualified Stock Option unless and until such approval is obtained.&#160; In the case of an Incentive Stock Option, the terms and conditions of such
      grant shall be subject to and comply with such rules as may be prescribed by Section 422 of the Code.&#160; If for any reason an Option intended to be an Incentive Stock Option (or any portion thereof) shall not qualify as an Incentive Stock Option, then,
      to the extent of such nonqualification, such Option or portion thereof shall be regarded as a Nonqualified Stock Option appropriately granted under the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Exercise Price.</u>&#160; Except as otherwise provided by the Committee in the case of Substitute Awards, the exercise price (&#8220;<u>Exercise Price</u>&#8221;) per share of
      Common Stock for each Option shall not be less than 100% of the Fair Market Value of such share (determined as of the date of grant); provided, however, that in the case of an Incentive Stock Option granted to an employee who, at the time of the
      grant of such Option, owns stock representing more than 10% of the voting power of all classes of stock of the Company or any Affiliate, the Exercise Price per share shall be no less than 110% of the Fair Market Value per share on the date of grant.&#160;
      Any modification to the Exercise Price of an outstanding Option shall be subject to the prohibition on repricing set forth in Section 14(b).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Vesting and Expiration.</u>&#160; Options shall vest and become exercisable in such manner and on such date or dates determined by the Committee and shall expire after
      such period, not to exceed ten years, as may be determined by the Committee (the &#8220;<u>Option Period</u>&#8221;); provided that, Options shall be subject to a vesting period of not less than one year; provided, however, that the minimum vesting period
      specified above will not apply: (1) to Options granted in payment of or exchange for other earned compensation (including performance-based Awards), (2) upon a Change in Control and an involuntary termination of service of the Participant by the
      Company (other than for Cause), (3) upon termination of service due to death,&#160; Disability or Retirement, (4) to a Substitute Award that does not reduce the vesting period of the Option being replaced, or (5) to one or more Options and/ or SARs
      covering an aggregate number of shares of Common Stock not in excess of five percent (5%) of the aggregate number of shares of Common Stock available for Awards under Section 5(b)(i) of the Plan over the Plan&#8217;s term&#8221;; and it is further <u>provided</u>,
      that if the Option Period (other than in the case of an Incentive Stock Option) would expire at a time when trading in the shares of Common Stock is prohibited by the Company&#8217;s insider trading policy (or Company-imposed &#8220;blackout period&#8221;), the Option
      Period shall be automatically extended until the 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day following the expiration of such prohibition; <u>provided</u>, <u>however</u>, that in no event shall the
      Option Period exceed five years from the date of grant in the case of an Incentive Stock Option granted to a Participant who on the date of grant owns stock representing more than 10% of the voting power of all classes of stock of the Company or any
      Affiliate; <u>provided</u>, <u>further</u>, that notwithstanding any vesting or exercisability dates set by the Committee, the Committee may, in its sole discretion, accelerate the vesting and/or exercisability of any Option, which acceleration
      shall not affect the terms and conditions of such Option other than with respect to vesting and/or exercisability provided, that, the Committee may not accelerate the vesting of an Option if such acceleration would reduce the vesting period to less
      than one year.&#160; Notwithstanding the foregoing, a Participant&#8217;s unvested Options shall immediately vest and become exercisable upon such Participant&#8217;s termination of employment or </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">service with the Company and its Affiliates due to death, Disability or Retirement, or as provided in Section 13 hereof.</font></div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">Unless otherwise stated in the applicable Award agreement, an Option shall expire earlier than the end of the Option Period in the following circumstances:</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If prior to the end of the Option Period, the Participant&#8217;s employment or service with the Company and all Affiliates is terminated without Cause
      or by the Participant for any reason other than Retirement, the Option shall expire on the earlier of the last day of the Option Period or the date that is 90 days after the date of such termination; provided, however, that any Participant whose
      employment or service with the Company or any Affiliate is terminated and who is subsequently rehired or reengaged by the Company or any Affiliate within 90 days following such termination and prior to the expiration of the Option shall not be
      considered to have undergone a termination.&#160; In the event of a termination described in this clause (i), the Option shall remain exercisable by the Participant until its expiration only to the extent the Option was exercisable at the time of such
      termination.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant dies or is terminated on account of Disability prior to the end of the Option Period and while still in the employ or service
      of the Company or an Affiliate, or dies following a termination described in clause (i) above but prior to the expiration of an Option, the Option shall expire on the earlier of the last day of the Option Period or the date that is one year after the
      date of death or termination on account of Disability of the Participant, as applicable.&#160; In such event, the Option shall remain exercisable by the Participant or his or her beneficiary determined in accordance with Section 15(g), as applicable,
      until its expiration only to the extent the Option was exercisable by the Participant at the time of such event.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant ceases employment or service of the Company or any Affiliates due to a termination for Cause, the Option shall expire
      immediately upon such cessation of employment or service.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant terminates by reason of Retirement prior to the end of the Option Period, the Option shall expire three years after the date of
      termination, or, if earlier, at the end of the Option Period.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant&#8217;s employment or service ceases on account of Disability at a time when the Participant has attained the age and service
      requirements for Retirement, the Participant shall receive the better of the treatment under clause (ii) and clause (iv) above.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Terms and Conditions</u>.&#160; Except as specifically provided otherwise in an Award agreement, each Option granted under the Plan shall be subject to the
      following terms and conditions:</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Option or portion thereof that is exercisable shall be exercisable for the full amount or for any part thereof.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Each share of Common Stock purchased through the exercise of an Option shall be paid for in full at the time of the exercise.&#160; Each Option shall cease to be
      exercisable, as to any share, when the Participant purchases the share or when the Option expires.</div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subject to Section 15(b), Options shall not be transferable by the Participant except by will or the laws of descent and distribution and shall be exercisable during
      the Participant&#8217;s lifetime only by the Participant.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; margin-bottom: 12pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; At the time of any exercise of an Option, the Committee may, in its sole discretion, require a Participant to deliver to the Committee a written representation that the
      shares of Common Stock to be acquired upon such exercise are to be acquired for investment and not for resale or with a view to the distribution thereof.&#160; Upon such a request by the Committee, delivery of such representation prior to the delivery of
      any shares issued upon exercise of an Option shall be a condition precedent to the right of the Participant or such other person to purchase any shares.&#160; In the event certificates for shares are delivered under the Plan with respect to which such
      investment representation has been obtained, the Committee may cause a legend or legends to be placed on such certificates to make appropriate reference to such representation and to restrict transfer in the absence of compliance with applicable
      federal or state securities laws.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Method of Exercise and Form of Payment.</u>&#160; No shares of Common Stock shall be delivered pursuant to any exercise of an Option until payment in full of the
      Exercise Price therefor is received by the Company and the Participant has paid to the Company an amount equal to any Federal, state, local and non-U.S. income and employment taxes required to be withheld.&#160; Options which have become exercisable may
      be exercised by delivery of written or electronic notice of exercise to the Company or its designee (including a third party administrator), or telephonic instructions to the&#160; extent provided by the Committee, in accordance with the terms of the
      Option accompanied by payment of the Exercise Price.&#160; The Exercise Price and all applicable required withholding taxes shall be payable (i)&#160;in cash, check, cash equivalent and/or shares of Common Stock valued at the Fair Market Value at the time the
      Option is exercised (including, pursuant to procedures approved by the Committee, by means of attestation of ownership of a sufficient number of shares of Common Stock in lieu of actual delivery of such shares to the Company); <u>provided</u>, that
      such shares of Common Stock are not subject to any pledge or other security interest; (ii)&#160;by such other method as the Committee may permit in its sole discretion, including without limitation:&#160; (A)&#160;in other property having a fair market value on the
      date of exercise equal to the Exercise Price and all applicable required withholding taxes or (B)&#160;if there is a public market for the shares of Common Stock at such time, by means of a broker-assisted &#8220;cashless exercise&#8221; pursuant to which the Company
      is delivered (including telephonically to the extent permitted by the Committee) a copy of irrevocable instructions to a stockbroker to sell the shares of Common Stock otherwise deliverable upon the exercise of the Option and to deliver promptly to
      the Company an amount equal to the Exercise Price and all applicable required withholding taxes or (C)&#160;by means of a &#8220;net exercise&#8221; procedure effected by withholding the minimum number of shares of Common Stock otherwise deliverable in respect of an
      Option that are needed to pay for the Exercise Price and all applicable required withholding taxes.&#160; Any fractional shares of Common Stock shall be settled in cash.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(f)&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Notification upon Disqualifying Disposition of an Incentive Stock Option.</u>&#160; Each Participant Awarded an Incentive Stock Option under the Plan shall notify the
      Company in writing immediately after the date he makes a disqualifying disposition of any Common Stock acquired pursuant to the exercise of such Incentive Stock Option.&#160; A disqualifying disposition is any disposition (including, without limitation,
      any sale) of such Common Stock before the later of (A)&#160;two years after the date of grant of the Incentive Stock Option or (B)&#160;one year after the date of exercise of the Incentive Stock Option.&#160; The Company may, if determined by the Committee and in
      accordance with procedures established by the Committee, retain possession, as agent for the applicable Participant, of any Common Stock acquired pursuant to the exercise of an Incentive Stock Option until the end of the period described in the
      preceding sentence, subject to complying with any instruction from such Participant as to the sale of such Common Stock.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(g)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Compliance With Laws, etc.</u>&#160; Notwithstanding the foregoing, in no event shall a Participant be permitted to exercise an Option in a manner which the Committee
      determines would violate the Sarbanes-Oxley Act of 2002, or any other applicable law or the applicable rules and regulations of the Securities and Exchange Commission or the applicable rules and regulations of any </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">securities exchange or inter-dealer quotation service on which the Common Stock of the Company is listed or quoted.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(h)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Incentive Stock Option Grants to 10% Shareholders</u>.&#160; Notwithstanding anything to the contrary in this Section 7, if an Incentive Stock Option is granted to a
      Participant who owns stock representing more than ten percent of the voting power of all classes of stock of the Company or of a Subsidiary or a parent of the Company, the Option Period shall not exceed five years from the date of grant of such
      Option and the Option Price shall be at least 110 percent of the Fair Market Value (on the date of grant) of the shares subject to the Option.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>$100,000 Per Year Limitation for Incentive Stock Options</u>.&#160; To the extent the aggregate Fair Market Value (determined as of the date of grant) of shares of
      Common Stock for which Incentive Stock Options are exercisable for the first time by any Participant during any calendar year (under all plans of the Company) exceeds $100,000, such excess Incentive Stock Options shall be treated as Nonqualified
      Stock Options.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Stock Appreciation Rights.&#160; </font>(a)&#160; <u>Generally.</u>&#160; Each SAR granted under the Plan shall be evidenced by
      an Award agreement.&#160; Each SAR so granted shall be subject to the conditions set forth in this Section&#160;8, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award agreement.&#160; Any Option granted under the
      Plan may include tandem SARs.&#160; The Committee also may Award SARs to Eligible Persons independent of any Option.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Strike Price.</u>&#160; Except as otherwise provided by the Committee in the case of Substitute Awards, the strike price (&#8220;<u>Strike Price</u>&#8221;) per share of Common
      Stock for each SAR shall not be less than 100% of the Fair Market Value of such share (determined as of the date of grant).&#160; Notwithstanding the foregoing, a SAR granted in tandem with (or in substitution for) an Option previously granted shall have
      a Strike Price equal to the Exercise Price of the corresponding Option.&#160; Any modification to the Strike Price of an outstanding SAR shall be subject to the prohibition on repricing set forth in Section 14(b).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Vesting and Expiration.</u>&#160; A<font style="font-weight: bold;">&#160;</font>SAR granted in connection with an Option shall become exercisable and shall expire
      according to the same vesting schedule and expiration provisions as the corresponding Option. Accordingly, a SAR shall vest and become exercisable and shall expire in such manner and on such date or dates determined by the Committee and shall expire
      after such period, not to exceed ten years, as may be determined by the Committee (the &#8220;<u>SAR Period</u>&#8221;); provided that a SAR shall be subject to a vesting period of not less than one year; provided, however, that the minimum vesting
      period specified above will not apply: (1) to SARs granted in payment of or exchange for other earned compensation (including performance-based Awards), (2) upon a Change in Control and an involuntary termination of service of the Participant by the
      Company (other than for Cause), (3) upon termination of service due to death,&#160; Disability or Retirement, (4) to a Substitute Award that does not reduce the vesting period of the SAR being replaced, or (5) to one or more SARs and/or Options covering
      an aggregate number of shares of Common Stock not in excess of five percent (5%) of the aggregate number of shares of Common Stock available for Awards under Section 5(b)(i) of the Plan over the Plan&#8217;s term.&#160; Notwithstanding any vesting or
      exercisability dates set by the Committee, the Committee may, in its sole discretion, accelerate the vesting and/or the exercisability of any SAR, which acceleration shall not affect the terms and conditions of such SAR other than with respect to
      vesting and/or exercisability; provided that, the Committee may not accelerate the vesting of a SAR if such acceleration would reduce the vesting period to less than one year.&#160;&#160; If the SAR Period would expire at a time when trading in the shares of
      Common Stock is prohibited by the Company&#8217;s insider trading policy (or the Company-imposed &#8220;blackout period&#8221;), the SAR Period shall be automatically extended until the 30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>
      day following the expiration of such prohibition.&#160; Notwithstanding the foregoing, a Participant&#8217;s unvested SARs shall immediately vest and become exercisable upon such Participant&#8217;s termination of employment or service </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">with the Company and its Affiliates due to death, Disability or Retirement, or as provided in Section 13 hereof.</font></div>
    <div style="text-indent: 72pt; line-height: 1.25;">Unless otherwise stated in the applicable Award agreement, a SAR shall expire earlier than the end of the SAR Period in the following circumstances:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If prior to the end of the SAR Period, the Participant&#8217;s employment or service with the Company and all Affiliates is terminated without Cause or
      by the Participant for any reason other than Retirement, the SAR shall expire on the earlier of the last day of the SAR Period or the date that is 90 days after the date of such termination; provided, however, that any Participant whose employment or
      service with the Company or any Affiliate is terminated and who is subsequently rehired or reengaged by the Company or any Affiliate within 90 days following such termination and prior to the expiration of the SAR shall not be considered to have
      undergone a termination.&#160; In the event of a termination described in this clause (i), the SAR shall remain exercisable by the Participant until its expiration only to the extent the SAR was exercisable at the time of such termination.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant dies or is terminated on account of Disability prior to the end of the SAR Period and while still in the employ or service of
      the Company or an Affiliate, or dies following a termination described in clause (i) above but prior to the expiration of a SAR, the SAR shall expire on the earlier of the last day of the SAR Period or the date that is one year after the date of
      death or termination on account of Disability of the Participant, as applicable.&#160; In such event, the SAR shall remain exercisable by the Participant or his or her beneficiary determined in accordance with Section 15(g), as applicable, until its
      expiration only to the extent the SAR was exercisable by the Participant at the time of such event.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant ceases employment or service of the Company or any Affiliates due to a termination for Cause, the SAR shall expire immediately
      upon such cessation of employment or service.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant terminates by reason of Retirement prior to the end of the SAR Period, the SAR shall expire three years after the date of
      termination, or, if earlier, at the end of the SAR Period.</div>
    <div style="text-indent: 67.5pt; margin-left: 4.5pt; line-height: 1.25; margin-bottom: 12pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; If the Participant&#8217;s employment or service ceases on account of Disability at a time when the Participant has attained the age and service
      requirements for Retirement, the Participant shall receive the better of the treatment under clause (ii) and clause (iv) above.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Method of Exercise.</u>&#160; SARs which have become exercisable may be exercised by delivery of written (or electronic notice or telephonic instructions to the extent
      provided by the Committee) of exercise to the Company or its designee (including a third party administrator) in accordance with the terms of the Award, specifying the number of SARs to be exercised and the date on which such SARs were Awarded.&#160;
      Notwithstanding the foregoing, if on the last day of the Option Period (or in the case of a SAR independent of an Option, the SAR Period), the Fair Market Value exceeds the Strike Price, the Participant has not exercised the SAR or the corresponding
      Option (if applicable), and neither the SAR nor the corresponding Option (if applicable) has expired, such SAR shall be deemed to have been exercised by the Participant on such last day and the Company shall make the appropriate payment therefor.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>Payment.</u>&#160; Upon the exercise of a SAR, the Company shall pay to the Participant an amount equal to the number of shares subject to the SAR that are being
      exercised multiplied by the excess, if any, of the Fair Market Value of one share of Common Stock on the exercise date over the </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">Strike Price, less an amount equal to any Federal, state, local and non-U.S. income and employment taxes required to be withheld.&#160; The
        Company shall pay such amount in cash, in shares of Common Stock valued at Fair Market Value, or any combination thereof, as determined by the Committee.&#160; Any fractional shares of Common Stock shall be settled in cash.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(f)&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>Substitution of SARs for Nonqualified Stock Options</u>.&#160; The Committee shall have the authority in its sole discretion to substitute, without the consent of the
      affected Participant or any holder or beneficiary of SARs, SARs settled in shares of Common Stock (or settled in shares or cash in the sole discretion of the Committee) for outstanding Nonqualified Stock Options, provided that (i) the substitution
      shall not otherwise result in a modification of the terms of any such Nonqualified Stock Option, (ii) the number of shares of Common Stock underlying the substituted SARs shall be the same as the number of shares of Common Stock underlying such
      Nonqualified Stock Options and (iii) the Strike Price of the substituted SARs shall be equal to the Exercise Price of such Nonqualified Stock Options.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">
      <div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze56ad54ea7494d30a4417299c0af0ead" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right; font-weight: bold;">9.</td>
              <td style="width: auto; vertical-align: top;">
                <div><font style="font-weight: bold;">Restricted Stock and Restricted Stock Units.&#160; </font>(a)&#160; (i)&#160; <u>Generally.</u>&#160; Each grant of Restricted Stock and Restricted Stock Units shall be evidenced by an Award agreement.&#160; Each Restricted
                  Stock and Restricted Stock Unit grant shall be subject to the conditions set forth in this Section&#160;9, and to such other conditions not inconsistent with the Plan as determined by the Committee and may be reflected in the applicable Award
                  agreement.&#160; The Committee shall establish restrictions applicable to such Restricted Stock and Restricted Stock Units, including the Restricted Period, and the time or times at which Restricted Stock or Restricted Stock Units shall be
                  granted or become vested.&#160; The Committee may in its sole discretion accelerate the vesting and/or the lapse of any or all of the restrictions on the Restricted Stock and Restricted Stock Units which acceleration shall not affect any other
                  terms and conditions of such Awards.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Automatic Grants to Non-Employee Directors</u>.&#160; Notwithstanding any other provision of this Plan to the contrary, Restricted Stock Units shall
      be automatically granted to each Non-Employee Director in accordance with this Section&#160;9(a)(ii) without any additional required action by the Committee.&#160; On the first business day of each fiscal year of the Company, each Non-Employee Director on such
      date shall be granted a number of Restricted Stock Units determined by dividing $130,000 ($180,000 in the case of the Company&#8217;s Chairman) by the Fair Market Value of a share on such date (which number shall be rounded up to the next whole number of
      shares).&#160; Each Non-Employee Director who is initially elected or appointed to the Board during the fiscal year shall be granted on the date of such election or appointment a number of Restricted Stock Units, equal to the quotient (which number of
      shares shall be rounded up to the next whole number of shares) of (i)&#160;the product of $130,000 ($180,000 in the case of the Company&#8217;s Chairman) multiplied by a fraction, the numerator of which shall be the number of days remaining during the fiscal
      year and the denominator of which shall be 365, divided by (ii)&#160;the Fair Market Value of a share of Common Stock on such Non-Employee Director&#8217;s date of election or appointment.&#160; Except as otherwise provided in this Section 9, or as otherwise
      provided in the applicable Award agreement, or any applicable consulting, change in control, severance or other agreement between a Non-Employee Director and the Company or an Affiliate, the foregoing automatic grants of Restricted Stock Units shall
      have a Restricted Period of one year, and shall vest in full on the first anniversary of the date of grant, and thereafter the restrictions set forth in the applicable Award agreement shall have no further force or effect with respect to such
      Restricted Stock Units (and such Restricted Stock Units shall be treated as Released Units for purposes of Section 9(e)(ii)), provided that the Non-Employee Director remains in the service of the Company and its Affiliates throughout the one year
      period commencing on the date of grant.&#160; Each Non-Employee Director shall also be eligible to receive grants of additional Awards under the Plan; provided that, no Non-Employee Director shall be granted equity Awards under the Plan in any one
      calendar year having an aggregate Fair Market Value (measured on the date(s) of </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">grant) in such calendar year in excess of $250,000 in the aggregate (including the annual $130,000 ($180,000 in the case
        of the Company&#8217;s Chairman) grant provided for above in this clause (ii)).</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Stock Certificates; Escrow or Similar Arrangement.</u>&#160; Upon the grant of Restricted Stock, the Committee shall cause share(s) of Common Stock to be registered in
      the name of the Participant and held in book-entry form subject to the Company&#8217;s directions and, if the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than delivered to the Participant pending vesting
      and the release of the applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (i) an escrow agreement satisfactory to the Committee, if applicable, and (ii) the appropriate stock power
      (endorsed in blank) with respect to the Restricted Stock covered by such agreement.&#160; If a Participant shall fail to execute and deliver (in a manner permitted under Section 15(a) or as otherwise determined by the Committee) an agreement evidencing an
      Award of Restricted Stock and, if applicable, an escrow agreement and blank stock power within the amount of time specified by the Committee, the Award shall be null and void.&#160; Subject to the restrictions set forth in this Section&#160;9 and the
      applicable Award agreement, the Participant generally shall have the rights and privileges of a shareholder as to such Restricted Stock, including without limitation the right to vote such Restricted Stock (provided that any dividends payable on such
      shares of Restricted Stock shall be held by the Company and delivered (without interest) to the Participant within 15 days following the date on which the restrictions on such Restricted Stock lapse (and the right to any such accumulated dividends
      shall be forfeited upon the forfeiture of the Restricted Stock to which such dividends relate)). The Committee shall also be permitted to cause a stock certificate registered in the name of the Participant to be issued. To the extent shares of
      Restricted Stock are forfeited, any stock certificates issued to the Participant evidencing such shares shall be returned to the Company, and all rights of the Participant to such shares and as a shareholder with respect thereto shall terminate
      without further obligation or action on the part of the Company.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Restricted Stock Units</u>.&#160; No shares shall be issued at the time an Award of Restricted Stock Units is made, and the Company will not be required to set aside a
      fund for the payment of any such Award.&#160; At the discretion of the Committee, each Restricted Stock Unit (representing one share of Common Stock) Awarded to a Participant may be credited with cash and stock dividends paid in respect of one share of
      Common Stock (&#8220;<u>Dividend Equivalents</u>&#8221;).&#160; Subject to Section 15(c), at the discretion of the Committee, Dividend Equivalents may be either currently paid to the Participant or withheld by the Company for the Participant&#8217;s account, and interest
      may be credited on the amount of cash Dividend Equivalents withheld at a rate and subject to such terms as determined by the Committee.&#160; Dividend Equivalents credited to a Participant&#8217;s account and attributable to any particular Restricted Stock Unit
      (and earnings thereon, if applicable) shall be distributed to the Participant upon settlement of such Restricted Stock Unit and, if such Restricted Stock Unit is forfeited, the Participant shall have no right to such Dividend Equivalents.</div>
    <div style="margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Restrictions; Forfeiture</u>.&#160; (i)&#160; Restricted Stock Awarded to a Participant shall be subject to forfeiture until the expiration of the Restricted Period and the
      attainment of any other vesting criteria established by the Committee, and to the following provisions in addition to such other terms and conditions as may be set forth in the applicable Award agreement:&#160; (A) if an escrow arrangement is used, the
      Participant shall not be entitled to delivery of the stock certificate; and (B) the shares shall be subject to the restrictions on transferability set forth in the Award agreement.&#160; In the event of any forfeiture, the stock certificates shall be
      returned to the Company, and all rights of the Participant to such shares and as a shareholder shall terminate without further action or obligation on the part of the Company.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Restricted Stock Units Awarded to any Participant shall be subject to forfeiture until the expiration of the Restricted Period and the attainment of
      any other vesting criteria established by the Committee, and to such other terms and conditions as may be set forth in the applicable Award agreement.&#160; In the event of any forfeiture, all rights of the Participant to such Restricted Stock Units shall
      terminate without further action or obligation on the part of the Company.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding anything to the contrary in the Plan, except as otherwise provided in the applicable Award agreement, or any applicable employment,
      consulting, change in control, severance or other agreement between a Participant and the Company or an Affiliate, upon such Participant&#8217;s termination of employment or service with the Company and its Affiliates due to death, Disability or Retirement
      (unless waived by a participant prior to the grant of the applicable Award), or as provided in Section 13 hereof, such Participant&#8217;s outstanding Restricted Stock and Restricted Stock Units shall immediately vest in full, and the restrictions set
      forth in the applicable Award agreement shall have no further force or effect with respect to such Restricted Stock or Restricted Stock Units (and such Restricted Stock Units shall be treated as Released Units for purposes of Section 9(e)(ii));
      provided, however, that if the vesting of any Restricted Stock or Restricted Stock Units would otherwise be subject to the achievement of performance conditions, then:&#160; (A) all applicable performance criteria shall be deemed to have been attained at
      target levels and (B) if such termination of employment or service or Change in Control occurs on or prior to the date on which 50% of the applicable performance period has elapsed, only 50% of such Restricted Stock or Restricted Stock Units shall
      immediately vest.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Committee shall have the authority to remove any or all of the restrictions on the Restricted Stock and Restricted Stock Units whenever it may
      determine that, by reason of changes in applicable laws or other changes in circumstances arising after the date of the Restricted Stock Award or Restricted Stock Unit Award, such action is appropriate.</div>
    <div style="margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Delivery of Restricted Stock and Settlement of Restricted Stock Units.</u>&#160; (i)&#160; Upon the expiration of the Restricted Period with respect to any shares of
      Restricted Stock and the attainment of any other vesting criteria established by the Committee, the restrictions set forth in the applicable Award agreement shall be of no further force or effect with respect to such shares, except as set forth in
      the applicable Award agreement.&#160; If an escrow arrangement is used, upon such expiration, the Company shall deliver to the Participant, or his or her beneficiary, without charge a notice evidencing a book entry notation&#160; (or, if applicable, the stock
      certificate) evidencing the shares of Restricted Stock which have not then been forfeited and with respect to which the Restricted Period has expired (rounded down to the nearest full share).&#160; Dividends, if any, that may have been withheld by the
      Committee and attributable to any particular share of Restricted Stock shall be distributed to the Participant in cash or, at the sole discretion of the Committee, in shares of Common Stock having a Fair Market Value (on the date of distribution)
      equal to the amount of such dividends, upon the release of restrictions on such share and, if such share is forfeited, the Participant shall have no right to such dividends.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Unless otherwise provided by the Committee in an Award agreement, upon the expiration of the Restricted Period and the attainment of any other
      vesting criteria established by the Committee, with respect to any outstanding Restricted Stock Units, the Company shall deliver to the Participant, or his or her beneficiary, without charge, one share of Common Stock (or other securities or other
      property, as applicable) for each such outstanding Restricted Stock Unit which has not then been forfeited and with respect to which the Restricted Period has expired and any other such vesting criteria are attained (&#8220;<u>Released Unit</u>&#8221;); <u>provided</u>,
      <u>however</u>, that the Committee may, in its sole discretion, elect to (i)&#160;pay cash or part cash and part Common Stock in lieu of </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">delivering only shares of Common Stock in respect of such Released Units or (ii)&#160;defer the delivery of Common Stock (or
        cash or part Common Stock and part cash, as the case may be) beyond the expiration of the Restricted Period if such extension would not cause adverse tax consequences under Section 409A of the Code.&#160; If a cash payment is made in lieu of delivering
        shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock as of the date on which the Restricted Period lapsed with respect to such Restricted Stock Units, less an amount equal to any Federal,
        state, local and non-U.S. income and employment taxes required to be withheld.&#160; To the extent provided in an Award agreement, the holder of outstanding Released Units shall be entitled to be credited with dividend equivalent payments (upon the
        payment by the Company of dividends on shares of Common Stock) either in cash or, at the sole discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount of such dividends (<font style="color: rgb(0, 0, 0);">and interest may, at the sole discretion of the Committee, be credited on the amount of cash dividend equivalents at a rate and subject to such terms as determined by the Committee)</font>, which accumulated dividend equivalents (and
        interest thereon, if applicable) shall be payable at the same time as the underlying Restricted Stock Units are settled following the release of restrictions on such Restricted Stock Units, and, if such Restricted Stock Units are forfeited, the
        Participant shall have no right to such dividend equivalent payments.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(f)&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160; <u>Legends on Restricted Stock.</u>&#160; Each certificate representing Restricted Stock Awarded under the Plan, if any, shall bear a legend substantially in the form of
      the following in addition to any other information the Company deems appropriate until the lapse of all restrictions with respect to such Common Stock:</div>
    <div style="margin-right: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">TRANSFER OF THIS CERTIFICATE AND THE SHARES REPRESENTED HEREBY IS RESTRICTED PURSUANT TO THE TERMS OF THE CHILDREN&#8217;S PLACE, INC. 2011 EQUITY INCENTIVE <font style="color: #000000;">&#160;</font>PLAN AND A RESTRICTED STOCK AWARD AGREEMENT, DATED AS OF _____________, BETWEEN THE CHILDREN&#8217;S PLACE, INC. AND __________________.&#160; A COPY OF SUCH PLAN AND AWARD AGREEMENT IS ON FILE AT THE PRINCIPAL EXECUTIVE
      OFFICES OF THE CHILDREN&#8217;S PLACE, INC.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">10.</font>&#160; &#160; &#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">Other Stock-Based Awards. </font>&#160; The Committee may issue unrestricted Common Stock, rights to receive grants
      of Awards at a future date, or other Awards denominated in Common Stock (including, without limitation, performance shares or performance units), under the Plan to Eligible Persons, alone or in tandem with other Awards, in such amounts as the
      Committee shall from time to time in its sole discretion determine.&#160; Each Other Stock-Based Award granted under the Plan shall be evidenced by an Award agreement.&#160; Each Other Stock-Based Award so granted shall be subject to such conditions not
      inconsistent with the Plan as may be reflected in the applicable Award agreement including, without limitation, the payment by the Participant of the Fair Market Value of such shares of Common Stock on the date of grant.&#160; Notwithstanding anything to
      the contrary in the Plan, except as otherwise provided in the applicable Award agreement, or any applicable employment, consulting, change in control, severance or other agreement between a Participant and the Company or an Affiliate, upon such
      Participant&#8217;s termination of employment or service with the Company and its Affiliates due to death, Disability or Retirement, or as provided in Section 13 hereof, such Participant&#8217;s outstanding Other Stock-Based Awards shall immediately vest in
      full, and the restrictions set forth in the applicable Award agreement shall have no further force or effect with respect to such Other Stock-Based Awards; provided, however, that if the vesting of any Other Stock-Based Awards would otherwise be
      subject to the achievement of performance conditions, then:&#160; (A) all applicable performance criteria shall be deemed to have been attained at target levels and (B) if such termination of employment or service or Change in Control occurs </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">on or prior to the date on which 50% of the applicable performance period has elapsed, only 50% of each such Other Stock-Based Award shall immediately vest.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Performance Compensation Awards.&#160; </font>(a)&#160; <u>Generally.</u>&#160; The Committee shall have the authority, at or
      before the time of grant of any Award described in Sections&#160;7 through 10 of the Plan, to designate such Award as a Performance Compensation Award intended to qualify as &#8220;performance-based compensation&#8221; under Section&#160;162(m) of the Code.&#160; In addition,
      the Committee shall have the authority to make an Award of a cash bonus to any Participant and designate such Award as a Performance Compensation Award intended to qualify as &#8220;performance&#8209;based compensation&#8221; under Section&#160;162(m) of the Code.&#160;
      Notwithstanding the foregoing, a. any Award to a Participant who is a &#8220;covered employee&#8221; (within the meaning of Section 162(m) of the Code) for a fiscal year that satisfies the requirements of this Section 11 may be treated as a&#160; Performance
      Compensation Award in the absence of any such Committee designation and b. if the Company determines that a Participant who has been granted an Award designated as a Performance Compensation Award is not (or is no longer) a &#8220;covered employee&#8221; (within
      the meaning of Section 162(m) of the Code), the terms and conditions of such Award may be modified without regard to any restrictions or limitations set forth in this Section 11 (but subject otherwise to the provisions of Section 14 of the Plan).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>Discretion of Committee with Respect to Performance Compensation Awards.</u>&#160; With regard to a particular Performance Period, the Committee shall have sole
      discretion to select the length of such Performance Period [(subject to the proviso contained in the third sentence of Section 9(a)(i) above),] the type(s) of Performance Compensation Awards to be issued, the Performance Criteria that will be used to
      establish the Performance Goal(s), the kind(s) and/or level(s) of the Performance Goals(s) that is (are) to apply and the Performance Formula.&#160; Within the first 90 days of a Performance Period (or, if longer or shorter, within the maximum period
      allowed under Section&#160;162(m) of the Code), the Committee shall, with regard to the Performance Compensation Awards to be issued for such Performance Period, exercise its discretion with respect to each of the matters enumerated in the immediately
      preceding sentence and record the same in writing (which may be in the form of minutes of a meeting of the Committee).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Performance Criteria.</u>&#160; The Performance Criteria that will be used to establish the Performance Goal(s) may be based on the attainment of specific levels of
      performance of the Company (and/or one or more Affiliates, divisions or operational and/or business units, product lines, brands, business segments, administrative departments, units, or any combination of the foregoing) and shall be limited to the
      following: (i) net earnings or net income (before or after taxes); (ii) basic or diluted earnings per share (before or after taxes); (iii) net revenue or net revenue growth; (iv) gross revenue or gross revenue growth, gross profit or gross profit
      growth; (v) net operating profit (before or after taxes); (vi) return measures (including, but not limited to, return on investment, assets, capital, gross revenue or gross revenue growth, invested capital, equity, or sales); (vii) cash flow
      (including, but not limited to, operating cash flow, free cash flow, and cash flow return on capital), which may but are not required to be measured on a per share basis; ) (viii) earnings before or after taxes, interest, depreciation and/or
      amortization (including EBIT and EBITDA); (ix) gross or net operating margins; (x) productivity ratios; (xi) share price (including, but not limited to, growth measures and total shareholder return); (xii) expense targets or cost reduction goals,
      general and administrative expense savings; (xiii) margins; (xiv) operating efficiency; (xv) objective measures of customer satisfaction; (xvi) working capital targets; (xvii) measures of economic value added or other &#8216;value creation&#8217; metrics;
      (xviii) inventory control; (xix) enterprise value; (xx) sales; (xxi) stockholder return; (xxii) client retention; (xxiii) competitive market metrics; (xxiv) employee retention; (xxv) timely completion of new product rollouts; (xxvi) timely launch of
      new facilities; (xxvii) objective measures of personal targets, goals or completion of projects (including but not limited to succession and hiring projects, completion of specific acquisitions, reorganizations or other corporate transactions or
      capital-raising transactions, expansions of specific business operations and </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman',Times,serif;">meeting divisional or project budgets); (xxviii) system-wide revenues; (xxix) royalty income; (xxx) cost of capital, debt leverage year-end
        cash position or book value; (xxxi) strategic objectives, development of new product lines and related revenue, sales and margin targets, or international operations; or (xxxii)&#160; any combination of the foregoing.&#160; Any one or more of the Performance
        Criteria may be stated as a percentage of another Performance Criteria, or a percentage of a prior period&#8217;s Performance Criteria, or used on an absolute, relative or adjusted basis to measure the performance of the Company and/or one or more
        Affiliates as a whole or any divisions or operational and/or business units, product lines, brands, business segments, administrative departments of the Company and/or one or more Affiliates or any combination thereof, as the Committee may deem
        appropriate, or any of the above Performance Criteria may be compared to the performance of a group of comparator companies, or a published or special index that the Committee, in its sole discretion, deems appropriate, or as compared to various
        stock market indices.&#160; The Committee also has the authority to provide for accelerated vesting, delivery and exercisability of any Award based on the achievement of Performance Goals pursuant to the Performance Criteria specified in this
        paragraph.&#160; To the extent required under Section&#160;162(m) of the Code, the Committee shall, within the first 90 days of a Performance Period (or, if longer or shorter, within the maximum period allowed under Section&#160;162(m) of the Code), define in an
        objective fashion the manner of calculating the Performance Criteria it selects to use for such Performance Period.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Modification of Performance Goal(s).</u>&#160; In the event that applicable tax and/or securities laws change to permit Committee discretion to alter the governing
      Performance Criteria without obtaining shareholder approval of such alterations, the Committee shall have sole discretion to make such alterations without obtaining shareholder approval.&#160; Unless otherwise determined by the Committee at the time a
      Performance Compensation Award is granted, the Committee is authorized at any time during the first 90 days of a Performance Period (or, if longer or shorter, within the maximum period allowed under Section&#160;162(m) of the Code), or at any time
      thereafter to the extent the exercise of such authority at such time would not cause the Performance Compensation Awards granted to any Participant for such Performance Period to fail to qualify as &#8220;performance-based compensation&#8221; under Section
      162(m) of the Code, specify adjustments or modifications to be made to the calculation of a Performance Goal for such Performance Period, based on and in order to appropriately reflect the following events:&#160; (i) asset write-downs; (ii) litigation or
      claim judgments or settlements; (iii) the effect of changes in tax laws, accounting principles, or other laws or regulatory rules affecting reported results; (iv) any reorganization and restructuring programs; (v) nonrecurring items as described in
      Accounting Standards Codification Topic 225-20 (or any successor pronouncement thereto) and/or in management&#8217;s discussion and analysis of financial condition and results of operations appearing in the Company&#8217;s annual report to shareholders for the
      applicable year; (vi) acquisitions or divestitures; (vii) any other specific unusual or nonrecurring events, or objectively determinable category thereof; (viii) foreign exchange gains and losses; (ix) discontinued operations and nonrecurring
      charges; and (x) a change in the Company&#8217;s fiscal year.</div>
    <div style="margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Payment of Performance Compensation Awards.</u>&#160; (i)&#160; <u>Condition to Receipt of Payment.</u>&#160; Unless otherwise provided in the applicable Award agreement or any
      employment, consulting, change in control, severance agreement or other arrangement between a Participant and the Company or an Affiliate, a Participant must be employed by or rendering services to the Company or an Affiliate on the last day of a
      Performance Period to be eligible for payment in respect of a Performance Compensation Award for such Performance Period.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitation.</u>&#160; Unless otherwise provided in the applicable Award agreement, or any employment, consulting, change in control, severance or
      other agreement between a Participant and the Company or an Affiliate, a Participant shall be eligible to receive payment or delivery, as applicable, in respect of a Performance Compensation Award only to the extent that:&#160; (A)&#160;the Performance Goals
      for such period are achieved, as determined by the Committee in its sole discretion; and (B)&#160;all or some of the portion of such Participant&#8217;s Performance </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">21</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">Compensation Award has been earned for the Performance Period based on the application of the Performance Formula to such
        achieved Performance Goals, as determined by the Committee in its sole discretion, and except as otherwise provided in Section 13; <u>provided</u>, <u>however</u>, that in the event of the termination of a Participant&#8217;s employment or service due
        to death or Disability, (A) the Participant shall receive payment in respect of a Performance Compensation Award assuming for such purpose that the applicable performance criteria shall be deemed to have been attained at target levels and (B) if
        such termination of employment or service occurs on or prior to the date on which 50% of the applicable performance period has elapsed, only 50% of the Performance Compensation Award shall be payable.</font></div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Certification.</u>&#160; Following the completion of a Performance Period, the Committee shall review and certify in writing (which may be in the
      form of minutes of a meeting of the Committee) whether, and to what extent, the Performance Goals for the Performance Period have been achieved and, if so, calculate and certify in writing (which may be in the form of minutes of a meeting of the
      Committee) that amount of the Performance Compensation Awards earned for the period based upon the Performance Formula.&#160; The Committee shall then determine the amount of each Participant&#8217;s Performance Compensation Award actually payable for the
      Performance Period and, in so doing, may apply Negative Discretion.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Use of Negative Discretion.</u>&#160; In determining the actual amount of an individual Participant&#8217;s Performance Compensation Award for a Performance
      Period, the Committee may reduce or eliminate the amount of the Performance Compensation Award earned under the Performance Formula in the Performance Period through the use of Negative Discretion if, in its sole judgment, such reduction or
      elimination is appropriate; provided, that Negative Discretion shall not apply to any Performance Compensation Award (other than cash bonuses contemplated by the second sentence of Section 11(a)) unless the Award agreement so provides for the use of
      Negative Discretion.&#160; Unless otherwise provided in the applicable Award agreement, the Committee shall not have the discretion to (A)&#160;provide payment or delivery in respect of Performance Compensation Awards for a Performance Period if the
      Performance Goals for such Performance Period have not been attained; or (B)&#160;increase a Performance Compensation Award above the applicable limitations set forth in Section&#160;5 of the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(f)&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; <u>Timing of Award Payments.</u>&#160; Unless otherwise provided in the applicable Award agreement, Performance Compensation Awards granted for a Performance Period
      shall be paid to Participants as soon as administratively practicable following completion of the certifications required by this Section&#160;11.&#160; Any Performance Compensation Award that has been deferred shall not (between the date as of which the Award
      is deferred and the payment date) increase (i)&#160;with respect to a Performance Compensation Award that is payable in cash, by a measuring factor for each fiscal year greater than a reasonable rate of interest set by the Committee or (ii)&#160;with respect
      to a Performance Compensation Award that is payable in shares of Common Stock, by an amount greater than the appreciation of a share of Common Stock from the date such Award is deferred to the payment date.&#160; Unless otherwise provided in an Award
      agreement, any Performance Compensation Award that is deferred and is otherwise payable in shares of Common Stock shall be credited (during the period between the date as of which the Award is deferred and the payment date) with dividend equivalents
      (in a manner consistent with the methodology set forth in the last sentence of Section 9(d)(ii)).</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Changes in Capital Structure and Similar Events.&#160; </font>&#160; In the event of (a) any dividend (other than regular
      cash dividends) or other distribution (whether in the form of cash, shares of Common Stock, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, split-off, spin-off,
      combination, repurchase or exchange of shares of Common Stock or other securities of the Company, issuance of warrants or other rights to acquire shares of </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">22</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">Common Stock or other securities of the Company, or other similar corporate transaction or event (including, without limitation, a Change in Control) that affects the shares of Common Stock, or (b)
      unusual or nonrecurring events (including, without limitation, a Change in Control) affecting the Company, any Affiliate, or the financial statements of the Company or any Affiliate, or changes in applicable rules, rulings, regulations or other
      requirements of any governmental body or securities exchange or inter-dealer quotation service, accounting principles or law, such that in any case an adjustment is determined by the Committee in its sole discretion to be necessary or appropriate,
      then the Committee shall make any such adjustments in such manner as it may deem equitable, including without limitation any or all of the following:</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;adjusting any or all of (A) the number of shares of Common Stock or other securities of the Company (or number and kind of other securities or other
      property) which may be delivered in respect of Awards or with respect to which Awards may be granted under the Plan (including, without limitation, adjusting any or all of the limitations under Section 5 of the Plan) and (B) the terms of any
      outstanding Award, including, without limitation, (1) the number of shares of Common Stock or other securities of the Company (or number and kind of other securities or other property) subject to outstanding Awards or to which outstanding Awards
      relate, (2) the Exercise Price or Strike Price with respect to any Award or (3) any applicable performance measures (including, without limitation, Performance Criteria, Performance Formula and Performance Goals);</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; providing for a substitution or assumption of Awards (or Awards of an acquiring company), accelerating the delivery, vesting and/or exercisability
      of, lapse of restrictions and/or other conditions on, or termination of, Awards or providing for a period of time (which shall not be required to be more than ten (10) days) for Participants to exercise outstanding Awards prior to the occurrence of
      such event (and any such Award not so exercised shall terminate upon the occurrence of such event); and</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; cancelling any one or more outstanding Awards (or Awards of an acquiring company) and causing to be paid to the holders thereof, in cash, shares of
      Common Stock, other securities or other property, or any combination thereof, the value of such Awards, if any, as determined by the Committee (which if applicable may be based upon the price per share of Common Stock received or to be received by
      other shareholders of the Company in such event), including without limitation, in the case of an outstanding Option or SAR, a cash payment in an amount equal to the excess, if any, of the Fair Market Value (as of a date specified by the Committee)
      of the shares of Common Stock subject to such Option or SAR over the aggregate Exercise Price or Strike Price of such Option or SAR, respectively (it being understood that, in such event, any Option or SAR having a per share Exercise Price or Strike
      Price equal to, or in excess of, the Fair Market Value of a share of Common Stock subject thereto may be canceled and terminated without any payment or consideration therefor);</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><u>provided</u>, <u>however</u>, that in the case of any &#8220;equity restructuring&#8221; (within the meaning of the Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any
      successor pronouncement thereto) (&#8220;ASC 718&#8221;), the Committee shall make an equitable or proportionate adjustment to outstanding Awards to reflect such equity restructuring.&#160; Except as otherwise determined by the Committee, any adjustment in Incentive
      Stock Options under this Section&#160;12 (other than any cancellation of Incentive Stock Options) shall be made only to the extent not constituting a &#8220;modification&#8221; within the meaning of Section&#160;424(h)(3) of the Code, and any adjustments under this
      Section&#160;12 shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule&#160;16b-3 under the Exchange Act.&#160; The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment
      shall be conclusive and binding for all purposes.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">23</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Effect of Change in Control.&#160; </font>&#160; Except to the extent otherwise provided in an Award agreement, or any
      applicable employment, consulting, change in control, severance or other agreement between a Participant and the Company or an Affiliate, in the event of a Change in Control, notwithstanding any provision of the Plan to the contrary:</div>
    <div style="text-indent: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; In the case of Options, SARs and other Awards which are service-based and not subject to Performance Goals or other performance conditions, in the event that an Involuntary Termination of
      a Participant occurs within six (6) months prior to the occurrence of a Change in Control (in respect of Participants designated by the Committee) or within twelve (12) months following a Change in Control (in respect of all Participants), all
      Options and SARs held by such Participant shall become immediately exercisable with respect to all of the shares of Common Stock subject to such Options and SARs, and the Restricted Period (and any other non-performance based conditions) applicable
      to all Restricted Stock Awards, Restricted Stock Unit Awards and any other service-based Awards held by such Participant shall expire immediately, and all such Awards shall immediately become fully vested and the shares of Common Stock subject to all
      such Awards shall be immediately delivered to such Participant.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; In the case of equity Awards which are subject to the achievement of Performance Goals or other performance conditions, immediately prior to the occurrence of a Change in Control, the
      target number of shares of Common Stock set forth in the applicable Award agreement shall automatically convert into service-based Awards, and such service-based Awards shall vest and be delivered to the Participant on the vesting date set forth in
      the applicable Award agreement (without regard to the achievement of any applicable Performance Goals or other performance conditions), provided that the Participant is in the employ of the Company or an Affiliate on the applicable vesting date;
      provided that, in the event that an Involuntary Termination of a Participant occurs within six (6) months prior to the occurrence of a Change in Control (in respect of Participants designated by the Committee) or on or within twelve (12) months
      following a Change in Control (in respect of all Participants), all such unvested service-based Awards held by such Participant shall immediately become fully vested and the shares of Common Stock subject to such Awards shall be immediately delivered
      to such Participant.<br>
      <br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; In addition, in the event of a Change of Control, the Committee may in its discretion and upon at least 5 days&#8217; advance notice to the affected persons, cancel any
      outstanding Award and pay to the holders thereof, in cash, securities or other property (including of the acquiring or successor company) or any combination thereof, the value of such Awards based upon the price per share of Common Stock received or
      to be received by other shareholders of the Company in the event.&#160; Notwithstanding the above, the Committee shall exercise such discretion over any Award subject to Code Section 409A at the time such Award is granted.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger, consolidation or other
      reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">To the extent practicable, the provisions of this Section 13 shall occur in a manner and at a time which allows affected Participants the ability to participate in the Change in
      Control transaction with respect to the Common Stock subject to their Awards.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">14.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Amendments and Termination.&#160; </font>(a)&#160;&#160; <u>Amendment and Termination of the Plan.</u>&#160; The Committee may
      amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof at any time; <u>provided</u>, that no such amendment, alteration, suspension, discontinuation or termination shall be made without shareholder approval if such approval
      is necessary to comply with any tax or regulatory requirement applicable to the Plan (including, without limitation, as necessary to comply with any rules or </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">24</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt;">requirements of any securities exchange or inter-dealer quotation service on which the shares of Common Stock may be listed or quoted or for changes in GAAP to new accounting standards, to prevent
      the Company from being denied a tax deduction under Section&#160;162(m) of the Code); <u>provided</u>, <u>further</u>, that any such amendment, alteration, suspension, discontinuance or termination that would materially and adversely affect the rights
      of any Participant or any holder or beneficiary of any Award theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder or beneficiary.&#160; Notwithstanding the foregoing, no amendment shall be made
      to the last proviso of Section 14(b) without stockholder approval.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>Amendment of Award Agreements.</u>&#160; The Committee may, to the extent not inconsistent with the terms of any applicable Award agreement, waive any conditions or
      rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate, any Award theretofore granted or the associated Award agreement, prospectively or retroactively (including after a Participant&#8217;s termination of employment or
      service with the Company); <u>provided</u> that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would materially and adversely affect the rights of any Participant with respect to any Award
      theretofore granted shall not to that extent be effective without the consent of the affected Participant; <u>provided</u>, <u>further</u>, that without shareholder approval, except as otherwise permitted under Section 12 of the Plan, (i)&#160;no
      amendment or modification may reduce the Exercise Price of any Option or the Strike Price of any SAR, (ii)&#160;the Committee may not cancel any outstanding Option or SAR and replace it with a new Option or SAR (with a lower Exercise Price or Strike
      Price, as the case may be) or other Award or cash in a manner which would either (A)&#160;be reportable on the Company&#8217;s proxy statement as Options which have been &#8220;repriced&#8221; (as such term is used in Item 402 of Regulation S-K promulgated under the
      Exchange Act), or (B)&#160;result in any &#8220;repricing&#8221; for financial statement reporting purposes (or otherwise cause the Award to fail to qualify for equity accounting treatment) and (iii)&#160;the Committee may not take any other action which is considered a
      &#8220;repricing&#8221; for purposes of the shareholder approval rules of the applicable securities exchange or inter-dealer quotation service on which the Common Stock is listed or quoted.</div>
    <div style="line-height: 1.25; margin-bottom: 12pt;"><font style="font-weight: bold;">15.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">General.</font>&#160; (a)&#160; <u>Award Agreements.</u>&#160; Each Award under the Plan shall be evidenced by an Award
      agreement, which shall be delivered to the Participant and shall specify the terms and conditions of the Award and any rules applicable thereto.&#160; For purposes of the Plan, an Award agreement may be in any such form (written or electronic) as
      determined by the Committee (including, without limitation, a Board or Committee resolution, an employment agreement, a notice, a certificate or a letter) evidencing the Award.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(b)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Nontransferability.</u>&#160; &#160; (i)&#160; Each Award shall be exercisable only by a Participant during the Participant&#8217;s lifetime, or, if permissible under applicable law,
      by the Participant&#8217;s legal guardian or representative.&#160; No Award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Participant other than by will or by the laws of descent and distribution and any such
      purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or an Affiliate; provided that the designation of a beneficiary shall not constitute an assignment, alienation,
      pledge, attachment, sale, transfer or encumbrance.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding the foregoing, the Committee may, in its sole discretion, permit Awards (other than Incentive Stock Options) to be transferred by a
      Participant, without consideration, subject to such rules as the Committee may adopt consistent with any applicable Award agreement to preserve the purposes of the Plan, to:&#160; (A) any person who is a &#8220;family member&#8221; of the Participant, as such term is
      used in the instructions to Form&#160;S-8 under the Securities Act or any successor form of registration statements promulgated by the Securities and Exchange Commission (collectively, the &#8220;<u>Immediate Family Members</u>&#8221;); (B) a trust solely for the
      benefit of the Participant and his or her Immediate Family Members; (C) a partnership or limited </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">25</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">liability company whose only partners or shareholders are the Participant and his or her Immediate Family Members; or (D)
        any other transferee as may be approved either (I)&#160;by the Board or the Committee in its sole discretion, or (II)&#160;as provided in the applicable Award agreement; (each transferee described in clauses (A), (B), (C) and (D)&#160;above is hereinafter
        referred to as a &#8220;<u>Permitted Transferee</u>&#8221;); <u>provided</u> that the Participant gives the Committee advance written notice describing the terms and conditions of the proposed transfer and the Committee notifies the Participant in writing
        that such a transfer would comply with the requirements of the Plan.</font></div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; The terms of any Award transferred in accordance with the immediately preceding sentence shall apply to the Permitted Transferee and any reference
      in the Plan, or in any applicable Award agreement, to a Participant shall be deemed to refer to the Permitted Transferee, except that (A) Permitted Transferees shall not be entitled to transfer any Award, other than by will or the laws of descent and
      distribution; (B) Permitted Transferees shall not be entitled to exercise any transferred Option unless there shall be in effect a registration statement on an appropriate form covering the shares of Common Stock to be acquired pursuant to the
      exercise of such Option if the Committee determines, consistent with any applicable Award agreement, that such a registration statement is necessary or appropriate; (C) the Committee or the Company shall not be required to provide any notice to a
      Permitted Transferee, whether or not such notice is or would otherwise have been required to be given to the Participant under the Plan or otherwise; and (D)&#160; the consequences of the termination of the Participant&#8217;s employment by, or services to, the
      Company or an Affiliate under the terms of the Plan and the applicable Award agreement shall continue to be applied with respect to the Permitted Transferee, including, without limitation, that an Option shall be exercisable by the Permitted
      Transferee only to the extent, and for the periods, specified in the Plan and the applicable Award agreement.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(c)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Dividends and Dividend Equivalents.</u>&#160; The Committee in its sole discretion may provide a Participant as part of an Award with dividends or dividend
      equivalents, payable in cash, shares of Common Stock, other securities, other Awards or other property, on a current or deferred basis, on such terms and conditions as may be determined by the Committee in its sole discretion, including without
      limitation, payment directly to the Participant, withholding of such amounts by the Company subject to vesting of the Award or reinvestment in additional shares of Common Stock, Restricted Stock or other Awards; provided, that no dividend equivalents
      shall be payable in respect of outstanding (i) Options or SARs or (ii) unearned Performance Compensation Awards or other unearned Awards subject to performance conditions (other than or in addition to the passage of time) (although dividend
      equivalents may be accumulated in respect of unearned Awards and paid as soon as administratively practicable, but no more than 60 days, after such Awards are earned and become payable or distributable.</div>
    <div style="margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(d)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Tax Withholding.</u> (i)&#160; A Participant shall be required to pay to the Company or any Affiliate, and the Company or any Affiliate shall have the right (but not
      the obligation) and is hereby authorized to withhold, from any cash, shares of Common Stock, other securities or other property deliverable under any Award or from any compensation or other amounts owing to a Participant, the amount (in cash, Common
      Stock, other securities or other property) of any required withholding taxes in respect of an Award, its exercise, or any payment or transfer under an Award or under the Plan and to take such other action as may be necessary in the opinion of the
      Committee or the Company to satisfy all obligations for the payment of such withholding and taxes.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without limiting the generality of clause&#160;(i)&#160;above, the Committee may, in its sole discretion, permit a Participant to satisfy, in whole or in
      part, the foregoing withholding liability (but no more than the minimum required statutory liability withholding liability, if </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">required to avoid adverse accounting treatment of the Award as a liability Award under ACS 718) by (A)&#160;payment in cash;
        (B) the delivery of shares of Common Stock (which are not subject to any pledge or other security interest) owned by the Participant having a Fair Market Value equal to such withholding liability or (C)&#160;having the Company withhold from the number
        of shares of Common Stock otherwise issuable or deliverable pursuant to the exercise or settlement of the Award a number of shares with a Fair Market Value equal to such withholding liability.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(e)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; <u>No Claim to Awards; No Rights to Continued Employment; Waiver.</u>&#160; No employee of the Company or an Affiliate, or other person, shall have any claim or right to
      be granted an Award under the Plan or, having been selected for the grant of an Award, to be selected for a grant of any other Award.&#160; There is no obligation for uniformity of treatment of Participants or holders or beneficiaries of Awards.&#160; The
      terms and conditions of Awards and the Committee&#8217;s determinations and interpretations with respect thereto need not be the same with respect to each Participant and may be made selectively among Participants, whether or not such Participants are
      similarly situated.&#160; Neither the Plan nor any action taken hereunder shall be construed as giving any Participant any right to be retained in the employ or service of the Company or an Affiliate, nor shall it be construed as giving any Participant
      any rights to continued service on the Board.&#160; The Company or any of its Affiliates may at any time dismiss a Participant from employment or discontinue any consulting relationship, free from any liability or any claim under the Plan, unless
      otherwise expressly provided in the Plan or any Award agreement.&#160; By accepting an Award under the Plan, a Participant shall thereby be deemed to have waived any claim to continued exercise or vesting of an Award or to damages or severance entitlement
      related to non-continuation of the Award beyond the period provided under the Plan or any Award agreement, notwithstanding any provision to the contrary in any written employment contract or other agreement between the Company and its Affiliates and
      the Participant, whether any such agreement is executed before, on or after the date of grant.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(f)&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160; <u>International Participants.</u>&#160; Without limiting the generality of Section 4(d), with respect to Participants who reside or work outside of the United States of
      America and who are not (and who are not expect to be) &#8220;covered employees&#8221; within the meaning of Section 162(m) of the Code, the Committee may in its sole discretion amend the terms of the Plan or subplans or appendices thereto, or outstanding
      Awards, with respect to such Participants in order to conform such terms with the requirements of local law or to obtain more favorable tax or other treatment for a Participant, the Company or its Affiliates.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(g)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Designation and Change of Beneficiary.</u>&#160; Each Participant may file with the Committee a written designation of one or more persons as the beneficiary(ies) who
      shall be entitled to receive the amounts payable with respect to an Award, if any, due under the Plan upon his or her death.&#160; A Participant may, from time to time, revoke or change his or her beneficiary designation without the consent of any prior
      beneficiary by filing a new designation with the Committee.&#160; The last such designation received by the Committee shall be controlling; <u>provided</u>, <u>however</u>, that no designation, or change or revocation thereof, shall be effective unless
      received by the Committee prior to the Participant&#8217;s death, and in no event shall it be effective as of a date prior to such receipt.&#160; If no beneficiary designation is filed by a Participant, the beneficiary shall be deemed to be his or her spouse
      (or domestic partner if such status is recognized by the Company according to the procedures established by the Company and in such jurisdiction), or if the Participant is otherwise unmarried at the time of death, his or her estate.&#160; After receipt of
      Options in accordance with this paragraph, beneficiaries will only be able to exercise such options in accordance with Section 7(c)(ii) of this Plan.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-indent: 36pt;">(h)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Termination of Employment or Service</u>.&#160; Except as otherwise provided in an Award agreement, or any employment, consulting,
      change in control, severance or other agreement between a Participant and the Company or an Affiliate, unless determined otherwise by the Committee:&#160; (i) neither a temporary absence from employment or service due to illness, vacation or leave of
      absence (including, without limitation, a call to active duty for military service through a Reserve or National Guard unit) nor<br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">27</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">a transfer from employment or service with the Company to employment or service with an Affiliate (or vice-versa) shall be considered a termination of employment or service
      with the Company or an Affiliate; and (ii) if a Participant&#8217;s employment with the Company and its Affiliates terminates, but such Participant continues to provide services to the Company or its Affiliates in a non-employee capacity (including as a
      Non-Employee Director) (or vice-versa), such change in status shall not be considered a termination of employment or service with the Company or an Affiliate for purposes of the Plan.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(i)&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>No Rights as a Shareholder.</u>&#160; Except as otherwise specifically provided in the Plan or any Award agreement, no person shall be entitled to the privileges of
      ownership in respect of shares of Common Stock which are subject to Awards hereunder until such shares have been issued or delivered to that person.</div>
    <div style="margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(j)&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <u>Government and Other Regulations.</u>&#160; (i)&#160; The obligation of the Company to settle Awards in Common Stock or other consideration shall be subject to all
      applicable laws, rules, and regulations, and to such approvals by governmental agencies as may be required.&#160; Notwithstanding any terms or conditions of any Award to the contrary, the Company shall be under no obligation to offer to sell or to sell,
      and shall be prohibited from offering to sell or selling, any shares of Common Stock pursuant to an Award unless such shares have been properly registered for sale pursuant to the Securities Act with the Securities and Exchange Commission or unless
      the Company has received an opinion of counsel, satisfactory to the Company, that such shares may be offered or sold without such registration pursuant to an available exemption therefrom and the terms and conditions of such exemption have been fully
      complied with.&#160; The Company shall be under no obligation to register for sale under the Securities Act any of the shares of Common Stock to be offered or sold under the Plan.&#160; The Committee shall have the authority to provide that all shares of
      Common Stock or other securities of the Company or any Affiliate delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan, the applicable Award agreement, the
      Federal securities laws, or the rules, regulations and other requirements of the Securities and Exchange Commission, any securities exchange or inter-dealer quotation service upon which such shares or other securities of the Company are then listed
      or quoted and any other applicable Federal, state, local or non-U.S. laws, rules, regulations and other requirements, and, without limiting the generality of Section 9 of the Plan, the Committee may cause a legend or legends to be put on any such
      certificates of Common Stock or other securities of the Company or any Affiliate delivered under the Plan to make appropriate reference to such restrictions or may cause such Common Stock or other securities of the Company or any Affiliate delivered
      under the Plan in book-entry form to be held subject to the Company&#8217;s instructions or subject to appropriate stop-transfer orders.&#160; Notwithstanding any provision in the Plan to the contrary, the Committee reserves the right to add any additional
      terms or provisions to any Award granted under the Plan that it in its sole discretion deems necessary or advisable in order that such Award complies with the legal requirements of any governmental entity to whose jurisdiction the Award is subject.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Committee may cancel an Award or any portion thereof if it determines, in its sole discretion, that legal or contractual restrictions and/or
      blockage and/or other market considerations would make the Company&#8217;s acquisition of shares of Common Stock from the public markets, the Company&#8217;s issuance of Common Stock to the Participant, the Participant&#8217;s acquisition of Common Stock from the
      Company and/or the Participant&#8217;s sale of Common Stock to the public markets, illegal, impracticable or inadvisable.&#160; If the Committee determines to cancel all or any portion of an Award in accordance with the foregoing, the Company shall pay to the
      Participant an amount equal to the excess of (A) the aggregate Fair Market Value of the shares of Common Stock subject to such Award or portion thereof canceled (determined as of the </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">28</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">applicable exercise date, or the date that the shares would have been vested or delivered, as applicable), over (B) the
        aggregate Exercise Price or Strike Price (in the case of an Option or SAR, respectively) or any amount payable as a condition of delivery of shares of Common Stock (in the case of any other Award).&#160; Such amount shall be delivered to the Participant
        as soon as practicable following the cancellation of such Award or portion thereof.</font></div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(k)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>No Section 83(b) Elections Without Consent of Company.</u>&#160; No election under Section 83(b) of the Code or under a similar provision of law may be made unless
      expressly permitted by the terms of the applicable Award agreement or by action of the Committee in writing prior to the making of such election.&#160; If a Participant, in connection with the acquisition of shares of Common Stock under the Plan or
      otherwise, is expressly permitted to make such election and the Participant makes the election, the Participant shall notify the Company of such election within ten days of filing notice of the election with the Internal Revenue Service or other
      governmental authority, in addition to any filing and notification required pursuant to Section 83(b) of the Code or other applicable provision.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(l)&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160; <u>Payments to Persons Other Than Participants.</u>&#160; If the Committee shall find that any person to whom any amount is payable under the Plan is unable to care for
      his or her affairs because of illness or accident, or is a minor, or has died, then any payment due to such person or his or her estate (unless a prior claim therefor has been made by a duly appointed legal representative or a beneficiary designation
      form has been filed with the Company) may, if the Committee so directs the Company, be paid to his or her spouse, child, relative, an institution maintaining or having custody of such person, or any other person deemed by the Committee to be a proper
      recipient on behalf of such person otherwise entitled to payment.&#160; Any such payment shall be a complete discharge of the liability of the Committee and the Company therefor.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(m)&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; <u>Nonexclusivity of the Plan.</u>&#160; Neither the adoption of this Plan by the Board nor the submission of this Plan to the shareholders of the Company for approval
      shall be construed as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options otherwise than under this Plan, and such
      arrangements may be either applicable generally or only in specific cases.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(n)&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Trust or Fund Created.</u>&#160; Neither the Plan nor any Award shall create or be construed to create a trust or separate fund of any kind or a fiduciary
      relationship between the Company or any Affiliate, on the one hand, and a Participant or other person or entity, on the other hand.&#160; No provision of the Plan or any Award shall require the Company, for the purpose of satisfying any obligations under
      the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or otherwise to segregate any assets, nor shall the Company maintain separate bank accounts, books, records or other evidence of the existence
      of a segregated or separately maintained or administered fund for such purposes.&#160; Participants shall have no rights under the Plan other than as unsecured general creditors of the Company, except that insofar as they may have become entitled to
      payment of additional compensation by performance of services, they shall have the same rights as other employees under general law.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(o)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Reliance on Reports.</u>&#160; Each member of the Committee and each member of the Board (and their respective designees) shall be fully justified in acting or failing
      to act, as the case may be, and shall not be liable for having so acted or failed to act in good faith, in reliance upon any report made by the independent public accountant of the Company and its Affiliates and/or any other information furnished in
      connection with the Plan by any agent of the Company or the Committee or the Board, other than himself or herself.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">29</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(p)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Relationship to Other Benefits.</u>&#160; No payment under the Plan shall be taken into account in determining any benefits under any pension, retirement, profit
      sharing, group insurance or other benefit plan of the Company except as otherwise specifically provided in such other plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(q)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>Purchase for Investment</u>.&#160; Whether or not the Options and shares covered by the Plan have been registered under the Securities Act, each person exercising an
      Option under the Plan or acquiring shares under the Plan, may be required by the Company to give a representation in writing that such person is acquiring such shares for investment and not with a view to, or for sale in connection with, the
      distribution of any part thereof.&#160; The Company will endorse any necessary legend referring to the foregoing restriction upon the certificate or certificates representing any shares issued or transferred to the Participant upon the exercise of any
      Option granted under the Plan.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(r)&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160; <u>Governing Law.</u>&#160; The Plan shall be governed by and construed in accordance with the internal laws of the State of Delaware applicable to contracts made and
      performed wholly within the State of Delaware, without giving effect to the conflict of laws provisions thereof.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(s)&#160;&#160; &#160; &#160;&#160;&#160;&#160;&#160; <u>Severability.</u>&#160; If any provision of the Plan or any Award or Award agreement is or becomes or is deemed to be invalid, illegal, or unenforceable in any
      jurisdiction or as to any person or entity or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be
      construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be construed or deemed stricken as to such jurisdiction, person or entity or Award and the
      remainder of the Plan and any such Award shall remain in full force and effect.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(t)&#160;&#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160; <u>Obligations Binding on Successors.</u>&#160; The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting
      from the merger, consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets and business of the Company.</div>
    <div style="margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(u)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>409A of the Code.</u>&#160;&#160; (i) Notwithstanding any provision of the Plan to the contrary, it is intended that the provisions of this Plan comply with Section 409A of
      the Code, and all provisions of this Plan shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A of the Code.&#160; Each Participant is solely responsible and liable for the
      satisfaction of all taxes and penalties that may be imposed on or in respect of such Participant in connection with this Plan or any other plan maintained by the Company (including any taxes and penalties under Section 409A of the Code), and neither
      the Company nor any Affiliate shall have any obligation to indemnify or otherwise hold such Participant (or any beneficiary) harmless from any or all of such taxes or penalties.&#160; With respect to any Award that is considered &#8220;deferred compensation&#8221;
      subject to Section 409A of the Code, references in the Plan to &#8220;termination of employment&#8221; (and substantially similar phrases) shall mean &#8220;separation from service&#8221; within the meaning of Section 409A of the Code.&#160; For purposes of Section 409A of the
      Code, each of the payments that may be made in respect of any Award granted under the Plan is designated as separate payments.</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding anything in the Plan to the contrary, if a Participant is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of
      the Code, no payments or deliveries in respect of any Awards that are &#8220;deferred compensation&#8221; subject to Section 409A of the Code shall be made to such Participant prior to the date that is six months after the date of such Participant&#8217;s &#8220;separation
      from service&#8221; (as defined in Section 409A of the Code) or, if earlier, the Participant&#8217;s date of death.&#160; Following any applicable six month delay, all such </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">30</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman',Times,serif;">delayed payments or deliveries will be paid or delivered (without interest) in a single lump sum on the earliest date
        permitted under Section 409A of the Code that is also a business day.</font></div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25; margin-bottom: 12pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Unless otherwise provided by the Committee, in the event that the timing of payments in respect of any Award (that would otherwise be considered
      &#8220;deferred compensation&#8221; subject to Section 409A of the Code) would be accelerated upon the occurrence of (A) a Change in Control, no such acceleration shall be permitted unless the event giving rise to the Change in Control satisfies the definition
      of a change in the ownership or effective control of a corporation, or a change in the ownership of a substantial portion of the assets of a corporation pursuant to Section 409A of the Code and any Treasury Regulations promulgated thereunder or (B) a
      Disability, no such acceleration shall be permitted unless the Disability also satisfies the definition of &#8220;Disability&#8221; pursuant to Section 409A of the Code and any Treasury Regulations promulgated thereunder.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(v)&#160;&#160;&#160; &#160; &#160;&#160;&#160;&#160; <u>Clawback/Forfeiture</u>.&#160; Notwithstanding anything to the contrary contained herein, an Award agreement may provide that the Committee may in its sole discretion
      cancel such Award if the Participant, without the consent of the Company, while employed by or providing services to the Company or any Affiliate or after termination of such employment or service, violates a non-competition, non-solicitation,
      non-disparagement, non-disclosure covenant or agreement or otherwise has engaged in or engages in activity that is in conflict with or adverse to the interest of the Company or any Affiliate, including fraud or conduct contributing to any financial
      restatements or irregularities, as determined by the Committee in its sole discretion.&#160; The Committee may also provide in an Award agreement that if the Participant otherwise has engaged in or engages in any activity referred to in the preceding
      sentence, the Participant will forfeit any compensation, gain or other value realized thereafter on the vesting, exercise or settlement of such Award, the sale or other transfer of such Award, or the sale of shares of Common Stock acquired in respect
      of such Award, and must promptly repay such amounts to the Company.&#160; The Committee may also provide in an Award agreement that if the Participant receives any amount in excess of what the Participant should have received under the terms of the Award
      for any reason (including without limitation by reason of a financial restatement, mistake in calculations or other administrative error), all as determined by the Committee in its sole discretion, then the Participant shall be required to promptly
      repay any such excess amount to the Company.&#160; To the extent required by applicable law (including without limitation Section 302 of the Sarbanes Oxley Act and Section 954 of the Dodd Frank Act) and/or the rules and regulations of NASDAQ or other
      securities exchange or inter-dealer quotation system on which the Common Stock is listed or quoted, or if so required pursuant to a written policy adopted by the Company (as in effect and/or amended from time to time), Awards shall be subject
      (including on a retroactive basis) to clawback, forfeiture or similar requirements (and such requirements shall be deemed incorporated by reference into all outstanding Award agreements).</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Code Section&#160;162(m) Re-approval.</u>&#160; If so determined by the Committee, the provisions of the Plan regarding Performance Compensation Awards shall be submitted for
      re-approval by the shareholders of the Company no later than the first shareholder meeting that occurs in the fifth year following the year that shareholders previously approved such provisions following the date of initial shareholder approval, for
      purposes of exempting certain Awards granted after such time from the deduction limitations of Section 162(m) of the Code.&#160; Nothing in this subsection, however, shall affect the validity of Awards granted after such time if such shareholder approval
      has not been obtained.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">(x)&#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160; <u>Expenses; Gender; Titles and Headings.</u>&#160; The expenses of administering the Plan shall be borne by the Company and its Affiliates.&#160; Masculine pronouns and other
      words of masculine gender shall refer to both men and women.&#160; The titles and headings of the sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings shall
      control.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">31</font></div>
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt;">*&#160; &#160; &#160;&#160; *&#160; &#160; &#160;&#160; *</div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt;"> <br>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">As adopted by the Board of Directors of the Company on March 25, 2011.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">As approved by the shareholders of the Company on May 20, 2011.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">As amended and restated by the Compensation Committee of the Board of Directors of the Company on February 12, 2016.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">As amended and restated by the Compensation Committee of the Board of Directors of the Company on April 4, 2016.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">As amended and restated by the Board of Directors of the Company on May 25, 2016.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;">As amended and restated by the Board of Directors of the Company on May 14, 2020.</div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;"> <br>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; margin-bottom: 12pt;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;"> <font id="DSPFPageNumber" style="color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">32</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>eh2000744_ex0501.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Paul Weiss
         Document created using EDGARfilings PROfile 6.4.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div style="font-family: 'Times New Roman',Times,serif; text-align: right;"><font style="font-weight: bold;">EXHIBIT 5.1</font><br>
  </div>
  <div><br>
  </div>
  <div>
    <table id="zd755835880fe434e8793bb030a4d4aa9" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; text-align: left; vertical-align: top;">
            <div><img src="nyletterhead01.jpg"> <br>
            </div>
            <div> <br>
            </div>
            <div> <br>
            </div>
            <div> <br>
            </div>
            <div> <br>
            </div>
            <div>
              <div style="FONT: 8pt arial">WRITER'S DIRECT DIAL NUMBER</div>
              <div style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</div>
              <div><font style="FONT-SIZE: 8pt; FONT-FAMILY: arial">212-373-3000 </font>
                <div style="font-family: times new roman;">&#160;</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: arial">WRITER'S DIRECT FACSIMILE</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: arial">212-757-3990</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: arial">WRITER'S DIRECT E-MAIL ADDRESS</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</div>
                <div style="FONT-SIZE: 8pt; FONT-FAMILY: arial">&#160;<br>
                </div>
              </div>
            </div>
          </td>
          <td style="width: 50.00%;">
            <div style="text-align: right;">&#160;<img src="nyletterhead02.jpg"></div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div>May 15, 2020
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> The Children&#8217;s Place, Inc.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">500 Plaza Drive</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Secaucus, New Jersey 07094</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">Registration Statement on Form&#160;S&#8209;8</div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">Ladies and Gentlemen:</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We have acted as special counsel to The Children&#8217;s Place, Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the Registration Statement on
      Form&#160;S&#8209;8 (the &#8220;Registration Statement&#8221;) of the Company, filed with the Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the &#8220;Act&#8221;), and the rules and regulations thereunder (the &#8220;Rules&#8221;).&#160; You have asked us to
      furnish our opinion as to the legality of the securities being registered under the Registration Statement.&#160; The Registration Statement relates to the registration under the Act of the offer and sale of up to 600,000 shares of the Company&#8217;s common
      stock, par value $0.10 per share (the &#8220;Shares&#8221;), that may be issued by the Company pursuant to The Children&#8217;s Place, Inc. Fourth Amended and Restated 2011 Equity Incentive Plan (the &#8220;2011&#160;Plan&#8221;).</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table id="z5135f4c7ecf648589e9023f0fbddcea2" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50.00%;">
              <div><img src="header.jpg"> <br>
              </div>
            </td>
            <td style="width: 50%; text-align: right;">2<br>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In connection with the furnishing of this opinion, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the
      following documents (collectively, the &#8220;Documents&#8221;):</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;">the Registration Statement;</font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"> <br>
      </font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;">the 2011&#160;Plan;</font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"> <br>
      </font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;">the Amended and Restated Certificate of Incorporation of the
        Company, included as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) on June&#160;7, 2016; and</font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"> <br>
      </font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;">the Sixth Amended and Restated By-Laws of the Company, included as
        Exhibit&#160;3.2 to the Company&#8217;s Current Report on Form&#160;8&#8209;K filed with the Commission on June&#160;7, 2016</font></div>
    <div style="text-indent: 72pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;"> <br>
      </font></div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In addition, we have examined (i)&#160;such corporate records of the Company that we have considered appropriate, including a copy of the certificate of
      incorporation, as amended, and by-laws, as amended, of the Company, certified by the Company as in effect on the date of this letter and copies of resolutions of the board of directors of the Company relating to the issuance of the Shares, certified
      by the Company and (ii)&#160;such other certificates, agreements and documents that we deemed relevant and necessary as a basis for the opinions expressed below.&#160; We have also relied upon the factual matters contained in the representations and warranties
      of the Company made in the Documents and upon certificates of public officials and the officers of the Company.</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50.00%;">
              <div><img src="header.jpg"> <br>
              </div>
            </td>
            <td style="width: 50%; text-align: right;">3<br>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">In our examination of the documents referred to above, we have assumed, without independent investigation, (i)&#160;the genuineness of all signatures, (ii)&#160;the
      legal capacity of all individuals who have executed any of the documents reviewed by us, (iii)&#160;the authenticity of all documents submitted to us as originals, (iv)&#160;the conformity to the originals of all documents submitted to us as certified,
      photostatic, reproduced or conformed copies of valid existing agreements or other documents, (v)&#160;the authenticity of all the latter documents and (vi)&#160;that the statements regarding matters of fact in the certificates, records, agreements, instruments
      and documents that we have examined are accurate and complete.</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Based upon the above, and subject to the stated assumptions, exceptions and qualifications, we are of the opinion that, when issued in accordance with the
      terms of the 2011&#160;Plan and any applicable award agreement under the 2011&#160;Plan, the Shares will be validly issued, fully paid and non-assessable.</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The opinion expressed above is limited to the General Corporation Law of the State of Delaware.&#160; Our opinion is rendered only with respect to the laws, and
      the rules, regulations and orders under those laws, that are currently in effect.</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="line-height: 1.25;">
      <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50.00%;">
              <div><img src="header.jpg"> <br>
              </div>
            </td>
            <td style="width: 50%; text-align: right;">4<br>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">We hereby consent to use of this opinion as an exhibit to the Registration Statement. In giving this consent, we do not thereby admit that we come within the
      category of persons whose consent is required by the Act or the Rules.</div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> </div>
    <div style="text-indent: 72pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <table style="width: 100%; border-collapse: separate; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td colspan="2" style="width: 38%;" valign="top"><strong><br>
              </strong></td>
            <td style="width: 12%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 3%;" valign="top">&#160;</td>
            <td style="width: 35%;" valign="top">Very truly yours,<br>
            </td>
            <td style="width: 12%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 3%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 35%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 12%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 3%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 35%;" valign="top">&#160;</td>
            <td rowspan="1" style="width: 12%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; padding-bottom: 2px;" align="left" valign="top">
              <div style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;" align="left"><br>
              </div>
            </td>
            <td style="width: 3%; padding-bottom: 2px;" valign="top"><br>
            </td>
            <td style="width: 35%; border-bottom: #000000 2px solid;" align="left" valign="top">/s/ Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP</td>
            <td style="width: 12%; padding-bottom: 2px;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 3%;" valign="top">&#160;</td>
            <td style="width: 35%;" align="left" valign="bottom">PAUL, WEISS, RIFKIND, WHARTON &amp; GARRISON LLP</td>
            <td style="width: 12%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 3%;" valign="top">&#160;</td>
            <td style="width: 35%;" valign="top"><br>
            </td>
            <td style="width: 12%;" valign="top">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%;" valign="top">&#160;</td>
            <td style="width: 3%;" valign="top">&#160;</td>
            <td style="width: 35%;" valign="top">&#160;</td>
            <td style="width: 12%;" valign="top">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="line-height: 1.25; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;"><br>
      <br style="line-height: 1.25;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>eh2000744_ex2301.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Paul Weiss
         Document created using EDGARfilings PROfile 6.4.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="background-color: #FFFFFF; line-height: 1.25;">
      <div style="text-align: right; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">EXHIBIT 23.1</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    </div>
    <div style="background-color: #FFFFFF; line-height: 1.25;">
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">We consent to the incorporation by reference in this Registration Statement on Form S-8 for the registration of common stock pertaining
        to The Children&#8217;s Place, Inc. Fourth Amended and Restated 2011 Equity Incentive Plan of our reports dated March 19, 2020, with respect to the consolidated financial statements of The Children&#8217;s Place, Inc. and subsidiaries and the effectiveness of
        internal control over financial reporting of The Children&#8217;s Place, Inc. and subsidiaries included in its Annual Report (Form 10-K) for the year ended February 1, 2020, filed with the Securities and Exchange Commission.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">&#160;</div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 10pt;">/s/ Ernst &amp; Young LLP</div>
    <div style="background-color: #FFFFFF; line-height: 1.25;">
      <div style="line-height: 1.25;">Iselin, New Jersey</div>
      <div style="line-height: 1.25;">May 15, 2020</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25; margin-bottom: 10pt;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; margin-bottom: 10pt;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; margin-bottom: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>nyletterhead01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nyletterhead01.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0E.17AI9@  34T *@    @ # $   ,
M   !"?8   $!  ,    !#.0   $"  ,    #    G@$&  ,    !  (   $2
M  ,    !  $   $5  ,    !  ,   $:  4    !    I $;  4    !
MK $H  ,    !  (   $Q  (    B    M $R  (    4    UH=I  0    !
M    Z@   2( "  (  @ +<;    G$  MQL   "<0061O8F4@4&AO=&]S:&]P
M($-#(#(P,3@@*%=I;F1O=W,I #(P,3DZ,#,Z,C(@,30Z,#4Z,3    20   '
M    !# R,C&@ 0 #     0 !  "@ @ $     0  !:"@ P $     0   0@
M        !@$#  ,    !  8   $:  4    !   !< $;  4    !   !> $H
M  ,    !  (   (!  0    !   !@ ("  0    !   'Q0        !(
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MJ#Z4 "W5N[!4GB9CNP X).T[6_(\'T-)]LMN?](BX#D_..B'#_\ ?)X/H>M
M"FX@5PAFC#'. 6&3@@']2!]2*4W$(E6,RH)&)"J6&20,XQ].: $:Y@09::,
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MD6Q?(/R[  1@ #=G_@/3FM2@ HH ** "B@ HH ** *M]IUKJ,:1W47F*C%E
M8K@E2IZ'T8C\:@MM"TZT+M#"P9EV%FE=CC"K@$DXX51QZ4 *FB6$8&R)UQ"8
M 5E<$(0!C.>O YZ\=:=!I%G;1Q)%&X6*-XTS*Q(5R"W)//*CD\CM0!$OA_2T
MMFMTMMD3! P5V&=I)&2#DG)Z]34UAI5GIN[[)$4W  Y=FX!)[D]V/YT 7:*
M"B@ HH ** "B@ HH ** /__9 /_M$%Q0:&]T;W-H;W @,RXP #A"24T$!
M    #QP!6@ #&R5'' (   (    X0DE-!"4      !#-S_I]J,>^"05P=JZO
M!<-..$))300Z      $#    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    0 $<
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B
M:F,    !        4D="0P    ,     4F0@(&1O=6) ;^            !'
M<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N
M=$8C4FQT                0FQD(%5N=$8C4FQT                4G-L
M=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E
M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! !+     $  0$L     0 !.$))300F       .             #^    X
M0DE-! T       0    >.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      -O    !@             !"   !:
M   = $X 60 @ "T ( !, &4 = !T &4 <@!H &4 80!D "  ,  S #$ -0 Q
M #D ( !% $0 1P!! %( ,@    $                          0
M       %H    0@                      0
M   0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   0@     4F=H=&QO;F<   6@    !G-L:6-E<U9L3',    !
M3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M!V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I
M;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M    26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   $(
M %)G:'1L;VYG   %H     -U<FQ415A4     0       &YU;&Q415A4
M 0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .
M8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       )
M:&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=
M  EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.
M;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 0P @ #( ,  Q #@
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M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M            ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^-O'4%I<:AHS7"74GA^"*+$.G&="5D\IWGD.SY!+<R[=W+OX'\+?"7B[P/\
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MX^,7P^\*)XL^)?BKQ-H>JV>F1WES#/J%Y/?3RR)&9',4:PP^=L7. D,2CDJ
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M@VS\9>"?[-\86.H^)1>RP60ETF)7>XM90&E$WF-Y:;8\Y^;YU&20#T3]H?\
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M@DU?5[Y_-OM1\F/RX4D?  2-2P6-0J*7D8+N=RW94 %%%% !2,NZEILC;10
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M6)XVT_\ M#X)_OI[5E\:1^*9F\%67G0W4ITZ:\,8(U%/LH'E-L'EW,4IVL1
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M[ [Y .?84XZ7";O[1Y,/VC;M\W8-^/3=UQ5BB@"N=*@-W]H\F'[1MV>;L'F
M>F[KBF'1+0VKP?9;7R)&\QX_*78[9SN(Q@G(!SZU;HH KG3XS=>?Y<9GV>7Y
MA4;]O7&[KC/.*G5=BXI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nyletterhead02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nyletterhead02.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0XH17AI9@  34T *@    @ # $   ,
M   !"?8   $!  ,    !#.0   $"  ,    #    G@$&  ,    !  (   $2
M  ,    !  $   $5  ,    !  ,   $:  4    !    I $;  4    !
MK $H  ,    !  (   $Q  (    B    M $R  (    4    UH=I  0    !
M    Z@   2( "  (  @ +<;    G$  MQL   "<0061O8F4@4&AO=&]S:&]P
M($-#(#(P,3@@*%=I;F1O=W,I #(P,3DZ,#,Z,C(@,3,Z-# Z,CD   20   '
M    !# R,C&@ 0 #     0 !  "@ @ $     0   I2@ P $     0  !#X
M        !@$#  ,    !  8   $:  4    !   !< $;  4    !   !> $H
M  ,    !  (   (!  0    !   !@ ("  0    !   ,H         !(
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M&)B3\A8'OQR..>M% $E% !6=>W^EQ3B.^>-7C'F+YJD#@KRI(P3ED''.2.]
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M:FP,QW,!OPF%&-IZ-UP<XYFNX=0 N)%ANYFC"F#R;M5>1@.05(" 9 YYR2W
M'4 @DTR_L%NI[;[;?R--F.&74F4%64 GE?EP2V%&1T/7H1_VO:01P6FF74A=
M)0TUWJ"DQG<^S^_DDD$G'"G^(J%H VK%95ML3(Z.9'.'DWG!<D<_3'';ISC-
M% %FB@ JA-KND6T7FSZI911G'SO<(HY.!R3W((_"@"2'5+"Y8);WUM*Y!(6.
M56)Q]#59-0N6A+L;#)8JNVY)4MT SMZ[B 1V]R<4 )>WU];1_NQIXD9]B+/<
MF,,=H.,[3SG=Q@\ &ECU5?LQN);FP$7F!%D%P-OW\=?7;MX]3C/>@"];2M-
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MV?_M'G10:&]T;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   (
M   X0DE-!"4      !#-S_I]J,>^"05P=JZO!<-..$))300Z      $#
M$     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN
M=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M      MP<FEN=&5R3F%M951%6%0    0 $< <@!A '  : !I &, <P @ $,
M;P!P &D 90!R       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F
M9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M       !.$))30/X      !P  #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z     #_____________________________ ^@  #A"24T$
M"       $     $   )    "0      X0DE-!!X       0     .$))300:
M      -A    !@             $/@   I0    6 $X 60 @ "T ( !, &4
M= !T &4 <@!H &4 80!D "  ,  S #$ -0 Q #D    !
M          $              I0   0^                      $
M                    $     $       !N=6QL     @    9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   0^     %)G:'1L;VYG   "E     9S
M;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E
M241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0
M  Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0
M  I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG   $/@    !29VAT;&]N9P   I0    #=7)L5$585     $
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M!!0       0    !.$))300,     !5$     0   &$   "@   !)   MH
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MV3=:8@6L'-G[N3:DIIVX+7/+AT=I[;VVM8[VU^A4?;M^C0ZRC?\ 3K9;Z?\
MA+EL4;O0KW,-;MK=S'.WN:8^@ZR7;W-_?W*G^P\'3^<T $>HZ('J$:3_ ,,_
M_P ]_P WZBNU5MJJ94R=M;0ULF3 $<I*9I)))*?_TO54DDDE*25?*;G.(&*Y
MC06N#B^9#I;LV>U[?H^HWW?^"?S:KFKK<G]/01#H(86\QMT<;?<WW-;9_GT7
MI*=!)9 S<E])L9GXCA4[U;;((:*/3>[WR]^W99LLW[_Z.S_KBE3U!WK.;;G8
MVUCMKJPX&P$5,=MXK_2^J_U/YG^:]-)3JK-RNJXCJ0ZC-9CP^HNM>PN;M=^G
M]/W>FUOKU,<SU/S/^.38V=:ZZNLYF+>(+7ACO>YU;1Z[O;[6_I7;G_Z)GI_Z
M7V1];(]9\9>(VMN\VL EX97#7V[M_P!.IKJV6L?7^C24A9F66Y3:&]58+0T.
M=4*@)&RRN1ZGT?TK/M/_ *A4FYQ=5BBOJ0>ZZFBQCC1N=8TV,8[(]-@KV_:_
M4KI=_H/YQ/4;FN%EN3C68]=C1:X-$_1K#=T#VO=F^O8SW_X6O_KD1?E'8RC-
MPB^!5M:W_".#W,V;;'>CNLI_FG^K_A/]&DI'7U)MF.!5U;U++:]C;/0F'.KO
MOJNJJ8S^>;73ZCZW[Z_T/\U7ZBVJ';Z*W[MVYK3N(VS(^EM,;5DF^\6G?FX8
M?(=JT.(!/Z,D;F.]S0]E7Z3V?Z6_U?T.KC%QQZB][;'EC2ZQ@AKC&KV#W>QW
MYJ2DJ2222G__T_54DDDE*22224@?@X3R2_'J<3H26-,B#7W'^C=L_J*1Q<9S
M0QU3"UL@-+1 GZ6D?G(5V>VI]C/0N?Z7IR6,)!]0[1Z?[_I_X7_1JA97BLLL
M:VK-(#GN>&;H=87F[<UV[<[Z?L:UWV?[/^A_P7IUI3IC#PP_>**P\2-P8V8(
MVG6/W4WV'!]WZO5^D#FO]C?<'P;&OT]WJ;6[UD@8[3M]'J+2[;[H<1#S8YP@
M;FLX].]^SU/TU;_4]3],DYF*[(LL=1U /<;@6PXM]WH[_3@N:QKO1_0N:[_3
M_P"D24[+<>AL[:V-W$.,- D@[@X_VDU>+BU&:J65G35K0.-T?1'_  EG^>LF
MNC&%CF"K._6&MK<]Q<X /:_W"U[G6?H_M+]__J-/773576*VYY%1BN9<?T)]
M+_"?3^T;?4_2_P"#^AZ:2G4=AXCG;G45EW$EC28$^7\IR*UK6-#& -:T0UHT
M  [!<^:\:ND-&/U)P8QT;9F W<:RP/:S=9^YL_26?\9^DW<8!N/4T;B QH!L
M,OX_PCC^?^\DI(DDDDI__]3U5))))37R<5][@6Y%E #2W]&0.2UV_P!P<W=[
M-OO:] ?TRPMAN9>'003N\0X3 V^[W?ZV?I%?224XUSVXMIHORLN-P>+(;LAE
M1>]C;0W?Z6RKW[_TOJIOME-E8J-V6\TOLF^NM^I'Z'W^A.]KG9&_&;L_2>EZ
MO_"+6LR<>IP9;:RMS@2UKG $@0'.&[]W<U1&9AG07UG4MT>WZ0=Z9;S]+U/T
M?]=)3BW96-74_=E9VFH<&NB=&;-S6M:W;LW[++&7?SGJJUENK?E.QAE93+
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M74QCG&QS6@%YY) ^D?ZR2F:2222G_]DX0DE-!"$      %T    ! 0    \
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MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M+W1;F*)K0:U_9Z7\9FOH9K&UFME-Y_J+V6*.0;D?;EP#[HW@T;U]:^5=9_:
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MI?3>'=.\*^&KR]\8Q:O<70CL;">ZCN1=7ID9M@WI>708MQB9^F: .3\3?\%
MO!_A+0/$5]?Z;XBMF\-^#= \9-;2"TCEOEURXOK73M.A+7 C-])<V+0[7=(=
M\\ $Q#,4YKXL_P#!5_X:_![1_P"UM0L_%-YX?E^'@^(MMK-C!:RZ?>6[PW,U
MMIZ2FX4"^N8[.Y,*OMA<Q;/.#LBMK6OPC_9N^#OCO1_ K6/@'3-?UJY@U#2M
M$OKE99IC''<0VJ0Q3,VV&-);E8(% BC+R>4BG-8DTG[)>L?!OQM"U[\*;KP-
M?1'P_P")(A>1/8R17%Y=W8MF7=@*]S<WDB!!C<SE.%^4 ]/_ &D_VE+G]G,>
M'/(^'OC?QZWB34$TJ"+PY<:0DL4[<JICOKZU>3*"20^2)"D<$KOM1":Y.\_X
M*,_#[3?BS<^"[BW\50ZS9>(KOP[=%M)?[+ ]OITFHR7/G@^4T/DQ$!49IMS*
M/* W%;/QB7X$_M&^.? NC>*/$'A_5?$E_:2ZCX5BM/$,MG>7-O<1/OEMVMYD
M9XY8X).Y#K$_4*U;7PCU;X._'>2]O/!.I>$?%;:/K;:U<OIMXMT+?49K>2W^
MTMM8\R0M*@8_*R[L9P: .$U+_@I=I'A[P7>:MJ7PR^*UA.L6F7NEZ3]ETRZU
M#Q#8W]W':0W=I';WTBE1)(A:&5H[@!@!"S$*77/_  4\\%WWAG5-7\.:#XH\
M9:?I-S=+)/IEUI$,#65M!933ZD)[J^@A6W0W\$95W6X\P2 0D(36S;?#[]GS
MX+^.[;P,L/@K1?$GB:]L=3MM(ENO]*F>VG,MD(D9BT<,4RL8(5VQ(V_8@RP-
M3Q)\/_V<]0\)3ZI??\(/:Z3KESJ/C=]1AU V?VE\PPZA?">-U;RV)@CG"L$?
M<%<,&P0#N/!_[5/A_P =^#O%VO:/:ZIJ&D^$;*#4#<0FW9-6AFTV'48VM6$V
MU@89T7,AC&_."5PYO?"G]H;2_BWXPNM$LM-UJSN+/0-*\1O)>)"L;0:@)S%&
M-DKMYJ?9WW@@*-R[6?G' Z3\/?V?S\96OM,N/"]KXI\/ZE;>$YM/T_6I+:"V
MO5T__1["2PCE6 R"QQLC>(GRE&!A1CK/V7O!WPG\%Z7XDMOA9_PC[6^FZO+H
MVM?V;>F\:QO;4!&L969W:+[.&"K;Y"Q!L*J@XH ]4'%%%% !7'_&SX.VWQI\
M)V]C)J%]H]_IE]!JNEZC9A&FT^\@;=%*$D5HY ,D%'4@JQZ'##L** /FOXT?
M\$QO!O[3OAF[M?BE>+\1-4N?"VH^&H=3UK0M,FFTUKR1G-[:I]GV03Q[@J%1
MTC3=N(R=/Q;_ ,$\]!\=?&+4/&VJ>,/'5UJ6LR7,&I6C:E_Q+KW3)[!K)]--
MN%V) %*RJ4PXF4R;LR2[_H&B@#YWO?\ @GAH_BKP'XAT3Q3XLUWQ8=:TNPT&
MWN+^SL1_9VG65R;B"%8HX5CD;>QWR2*Q;"XVX.;FN?L!:/K7QYNOB0OC+QS:
M^)KB22!4AU +I\&FO9_93IBVVWR_LW"SX(+?:%$F<@"O?** /F73/^"7WA7P
MXT;Z3XH\6:7):Z/I%G9+$UN\%CJ&G745TNJ10O$R+-/)! 9XP!#(49_+6622
M1^JTC]B:VT?]F7Q#\.AXV\875QXDNI=1GUZ]NA>WEO=/+'+NA28/''$K1KMA
M"E!SQR:]PHH ^?[G]@/3?$L\>H^)O%_B#Q!XAFU>;5]1U*6UL8Q?E]$O=%CA
M-N(# (H[:^E<*4;=( 7+I\E5_AA_P3S\._##X3ZEX6L=<U"UM]4\0:3XA8Z9
MIUEI-G;S:=>V]Y&(;*UB2UB,KVZK-(D8>4-DME4V_1##<M?)_P ;/^"?MQXJ
M\6?'K6_"MCX=TK5/B1\/D\/:%<MJ,]O+;ZO*VK&^N9CY$J0K*+G3U\Q$F9OL
MQW18C17 .ZU#]@;P3>_M$3?%3R1#XXGUT:PVJ"PM6NO)_LQ-.-@93&7-N4C$
MH!;<DA)5E#,I;\&?V)E^ 5UI:>%_'7BBQT9(-,&M::UK93)X@N+"PM;"*YDD
M>$R0L]M96J2+"RH1""JHS.S>7?#']F#XQ_ WPW\-;GPYX4^&EUJ_A"ZUH:II
M]YX^N+.UU*.]2 1W+36?AZ&)I5,;*8EL8E551A(S%LX7C7]@_P"+'B'X]?'+
MQ5%:>!V_X65H=]9^'=0E\72I<>%KF;0(+)=D2:(+C:;N*3<WV\HL<S2+ )/D
M(!]5?#GX27?PR\0:B]KKEQ=:3JVH:EJ]U;7,"-(;F[GCD38Z@;8XE65 IR6\
MW).5&?!T_P""3/A,>,_B!K7_  D-[;W'CR/Q''<7%CHFFV6H1C6C<&=9KR.
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MXAOM*L-7@N+RU>WE,,ZM$K%@8I08WX^1OE;!XJ,_M7?#,?$[4/!7_"?>#_\
MA,-)\P7FB_VM#]OMS' +EU:'=O#+ RRE<9$9#XV\T >@45R*?'SP3(;;;XM\
M.-]LM].N[?&H1'SH=1F-O82+SRMS,#'$1Q(PPN3Q4?B']H7P+X2^&5WXUU3Q
M?X;T[P?87#6=SK5SJ,4=C!.MU]C,32DA0XN?W.TG/F?)][B@#LJ*\YM/VOOA
M7J'@Y?$5O\1O ]QH+:;?ZQ_:,6MV[VHL[!HUOK@R!MHCMFFB69B0(C(H;:2*
MN^*?VF_AWX'T?4-0UCQUX1TNPTFWL[N\N;O5X(8K>&\++:2,S,!MG9'6(_\
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M\K)+]AE!!<^7N3[^3MZCX3_M2:WXS\0>$=)\0>"I/#VH>+AJTT CO9IDAM[
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M]I%O UKX-\1'1[B_M],L?$<D4\-G=SSZ+!K$0W20+"FZ&X$>SSC-Y@QY1ZT
M>4^-_P!K_P#:&NO@EX9U+X?R>!/&GB3[+KVI>(&7PQJ4%G MBEH8K: -(KO(
M?M!;.W=* PC3<A5O<OVEOVA_$W@;P?X%O]%OM/T#1_$T;3:GXFN?#-]K=OIG
M[F.2&+['"\4RF=F<!Y"H3R]K#>ZBJ7Q5_;_A^'W[.OPE\?6/@S7M>E^,,EG'
MIFD6ZR2W-F9]'NM6/FK;Q32-LALY%/E1O\Q!.U SKVGQN_:)U+X'?!O1_$-U
MX+U[6-?U:6WM6T328YM0>SN)(FD=9'MX9)#%'L=3(D+<[<JJDLH!YYJ?[:GB
MG2_VG?!_AN/P?X@U+P-=6UGIWB#78/"]]'#:ZI?Q":VD61O]7!%B&*6-T9@V
MI1,TD8MI0_F?@']L+X\?$3X _$75F_X1O2_%7A.VCU>VFL_!6IWVD[/+D\S3
M/+N)K2\>\#A6.8EV(5R&9RJ>T>"?VR]6^(?Q@\":!HO@NWU+P]X]\/3>);3Q
M%:^([>:WCM;<V4=S^[";F9)K^%  1O"R'Y=H4^6_#G_@KW'\1OV=M0\>6OPN
M\8)-9S>'8HM+,-TTL_\ ;3QK;*/]%$KR1K*CR+##*OER1LKN&. #T[P-^U!J
M7@CXY:I\/?B%K5G=:K]FTM-$NK#PM>V<.JW%PDOG-D//&JA_*4*9!LP=S'/&
M+_P35_:8\>?M'>$=:NOB'J7AMM<M3"ZZ3I.@7VG-IL;A_P#7/<L0[EE92B9V
M>7DLP<8O67[<6O7WQ^\+_#J+X9ZTVLZQH>E^(-4F^TRFUT6WOI[^-0\BVY57
M1-.N)-MP;<OE$3<^]4[3]G3X^>)OC/XJ\;:7K_@-_!Y\%ZE%I,LIUN'4%N[A
MK6"[(41JI51#=0'<>K%QCY<D ]:HI%^[2T %%%% !1110 5C>.?'VD_#;06U
M36[Q+#3TG@MFG9691)-,D,2D*"?FDD1<XP,Y.!S6S7%_'SX00?'GX8:AX7N-
M8UCP\M[+;7$>I:4MLUY9S07$=Q%)&+F&:$D/$G$D3J1D$4 5OBO^TYX'^!^M
M6&G^*->ATNZU!#. 8)IDM+=6"-=7+QHRVMJK,JFXG,<(9@I<$@5%I'[57P_U
M[7]3TJT\36$VI:+XB_X1._M0LGFV>J?9OM0MG7;E28/W@8_(R]&-<'KO[#+>
M*+;?J?Q6^*%YJFI::="\2:F!HL%SXNTL2W$D5C=K%IR11)%]LNE26SCMK@"=
MLREL,'-_P3Y\$I\2]$\60WWB:UUC0]?N=<C:VN8(H[N.:VDMQI\ZB("6SBW^
M;$K?O(Y5W"7#R!P#=\&?MX?"WQWX-U#7K/Q)-:Z;IMK!?2?VII%]I=Q<6T[!
M+>>WM[J&.:YBFD(CB>!'660A$+/\M7]&_;/^&.O:AX:LX/%EG'J'B^/49-*L
MKF":VNIVT]5:^@>&1%DBN(%<&2WE595P^4^1L>?^#/\ @G)I7AKP;!I>J?$C
MXE^*;[1].L=+\.ZQJ3:1#>>%X;.>&XM_LJ6EA!;.5GMK=R;J&??Y*JVY"R->
MU#_@G7X1\4Z!<6?B37/&'BB\U*UOX]3U2^N+6&^U*[NFLF&H%[>WB6"ZM_L%
ML('M5A2+9PA.#0!Z!XY_:B\%_#SX7Z#XRU"_U*;0?%#6RZ3)INC7VI7&H&XB
M,T(CMK:&2<EHP6QY? !SBHK+]K/P#?>--)\.KK-Q'K.L6UO=1VT^F7<)LQ<#
M-LEVSQ!;.:;!$4-R8I)2K!%8@@<I\9?V&]!^,W[./@WX;WGB#Q)9:?X':P>R
MU);/2K^[N&M+=H(VGBOK*XM)"RL2W^CCYN5V\"IO W['4GPZ\>QZ_IGQ*^(L
M$FH2VEWXELU72$M/&-[;6T%I'>7:I8*T,IM[6VB9;%K6)EMT!C/.X W_  /^
MV-\-?B1K=KINB>*K34+R^U%=,M$2"95O)&M[BYCDA9D"R6\L5I=&*Y0F"4VT
MRQR,R,HM:I^U)X/TWX4Z;XVBGU[5_#>L3^193Z+X=U+5IKHY<!T@M;>28Q'R
MV(EV>65VL&*LI/FWAW_@GA9V/PN\<>&=<^)WQ0\72>.)+>Y?6]3;1[?6M'N[
M>4S07=M=66GV[&:*7RW0S^<L9A0(JKN5O5O%WP/TOQ1\#Y?A]!/J6A>'I=.B
MT<KI4JV\Z6*JJ-;H^T^6KPJ8BT8615=C&\;A74 S?^&N/AXO@71O$S^)+>'1
M?$&@7?BG3[B6WGC^T:9:Q1RW%SL9 ZK''+&Q#*&^<8!-=9H_Q#T?Q%XGU71+
M.\6;5-%AMKB]A$;#R([@.86W$!3N$;_=)QMYQQ7F?B[]BCP[\0O'NK:IKFM>
M)-1T.^\+7OA&Q\,JUI:Z1H-C>0V\-V+3R+>.Y5I4MHA^\GD5""8UCR:N?"W]
MF;4/A//>7B_$3Q?XGU[6-1M)]4UC7K?3#<W=E;(R1V"QVEI;6\<0WOAUB$N9
M&)D;   *WQ0T+X(WFB^*/#/B[PWX(OM+;5=/U'7=.U'0(KBUN-1U&=;:TGE1
MHBDMQ-,$0/\ ,X.-Q Q4.F_'WX(>*K72([74/"NH1^"/$U_X?TR./3O,_P"$
M>UK3;"Z-U!$OE_Z-/%8BZY4*3#(P4LL@#3?%O]C?2_B[\4K?Q)<>*/&&DVC3
MZ7<ZOH6GR68TWQ!)IEW]KL6N#+;27,?E3 -_HT\&\ !]X&*Y>Z_X)I^!9OB%
MH?BB/5?%MKK6CW.NW#SPW5N@U4:K_:&Z.Z3R-LBVIU2[-L<!XO,8%G5Y X!E
M:AXL_9A\<^(='\%WW@3P_JG]FP3^,M,AN/AG=R:99QW*-J$^I13M9?9D\YBS
MO*K@O,2I)F.VDM?BQ^S7)J\/QDB\#Q#Q+XBU*/2[;7_^%5:FOB+6KF2P9U\E
M?L'VVX4V5NW[V-6010E=P"XKTG1OV2M#T1+=(]5\02?9_ \?@)?,DM_FLDZ3
MG$(_T@]R/W?_ $S%>>^"_P#@FO#\./A#X7\(Z#\7/B9HJ^"]<77-"U.PTGPK
M:W6G/]@N;!X1%'HRVLD<D5U*S-+ \I?!$@ P0"U8?LZ?LJP?!#2;RQ^&GP5;
MX>^(M4L9+'[)X4L'TRYOGWV=K($2$HLB_:)8 Y ,8ED0E06%2?&#XP?LTZ/^
MS]9Z?XZB\!K\,=%TV'4+&QU?P_OT>VL8KN/3K>>"%X3'Y/G30I$\8VLDL;QD
MQLKGL==_8W\)^)_@-I'PYU5M2U;P_IVK6NLW0OO(NI-:N(;Y;]_M8DB:-TGN
M 3(J(@VLRIY8P!SFI_\ !/7PMKC>'OM_B+QQ?1^%GLETU+F^@F:"&SU^RURT
MMVD: R2)%+86UN#([.UNA#N\K&:@#8UCXP_!CX6:U;S+'H<6M>$W/@RQATC0
M)+W4;%9[6RU&2PM8K6%YC ;;[#<2+"IB5(XW? CRO)^,KG]F/5_%.G_#S6_"
M/@/4H[G2-#TZW2?P7]IT&.P665]%M&OOLS6,<8F:3[) TJ_O),1+O<!H7_X)
M;^!=#TC6K?PKKWC3P1-K&H7ERMQI<UC<'3;.[M-/M;C2[>*]M;B!;%DTNQ*Q
MM&S0F!!$\2*J#3C_ .">>CVNOV+6_C[XEP^%X],TG2K[PP]Y8W-CKD6FY-L;
MJZFM'U)V).9"MV@DQA@59E8 Y>2Z_9!TT7VOMX3^%-NOP=TJ;4H-4/@V.-=)
MT[3;EYI[C3I_LX$]O9W4TC2/9F1()YCN*2/@^Y?"_P =?#_5?B-XQT/PC<>'
MV\1V[V>M^)8M-@5)'DO+<+;7-PZJ!)));VR ,26\N*,'"[*\OLO^";OAFT\"
M7GA63Q?X^NO"UOX?N?"OAK29IK#[-X)TRXB2![>QVV@>3$,<<227K74D<:D*
MR[Y-_H/P4_96\*_ #QQX@UKPS'J5G_PD=K;6UQ:37/VB"/R);J571G!EW'[4
MR8>1E2.&&-%1(U6@#TRBBB@ HHHH **** "BBB@ Q1BBB@ (R*^7_BS_ ,$X
MO#GC7XQ_%WQMIGA3X>VNO_$#P&GAW3]3DTJ--0MM2==5CNKJ681,P6>&\M(W
M<%G9;;:RE405]044 ?&?P8_8G^(7[/GP^^'L7A/P1\&]-UGP+KE_?S6L&N/9
M6NKQW6GO;&:2:TT:$+.&9 0+8ADA3+EN0R\_X)\^*]2_:Q^*7Q&N?#OPPN+S
MXCZ;-!:ZQ+>[]3\.RR>'K/32D)_LP3NGGVL@W?;$4PW4A\D/D-]GT4 ?(/PW
M_P""4VG_  6\"^ ]'\&^)]9\,RZ-K]MKFM76FO:VN&BT:_L&-E;QVBVJ2227
M:&21H!)*B_.[,J <WKW_  3)\:7/@:VT7^TO"?B"\^PZE8:=K>KWEU'?> KN
MXU34;M=>TU8(52346CO8?,V?8SOLE59Q'(0GW%10!\D^ O\ @G9X@^'_ ,?_
M  ]XTL_$]E]A_P"%G:]X^\2Z2_G2PZFUW9ZO9V,\)8_N;J&WO[6&5<&*1+.)
ME"NFY[7_  3&_8<US]B7X+:GX5U#0_A_HVK7%C8V[>(?#TD<]UK$T%L83+<H
MNG6?"N#*@D>XD+7$P:4\%OJRB@#Y7\4_L<_%'QOXV^#6K2>.?"4>C?#>[TR_
MO=%U#0;N[NI+R&*XBOKN"]COHU:6X2=E!GMY-@9CD%W#=-^R%^RSX]^!'Q=^
M(WB;QMXR\)^,I_'D>FR/=Z3X?NM(N9;FV^TH\DZ37MTA_=26\:"(QJ$A "+M
MRWT$!MHH ^(/ _\ P3T\>VO@+Q+:Z]H?PQFFUGQ!9ZWJ'AZ#Q!?S>'?&<<45
MW#):Z@DEF) 6\ZWFDN)Q?2W4MN@F_=I&B>Y?LG_ /Q9\#(K>SUK7DU.PM]"@
MLUMXGDDAM[C[;>W'E0M(3(T%O!/!:Q-(?,:.V0OR*]MH"XH ^2M5_P""<&E^
M'='^+UWX7^'_ ,*+;4OB+<6=A!I$$(T?2Y=+MY!+F\>&TD$]W+/)=32&6":-
MPT,+K)&C&3 \+?\ !.+Q[X<\;?!75)_%&DZO_P *RTO2-+AEO[N6X;P_%9W5
MR]R+:)X&6\GO;&>"RENBUFRFRCG6/#"VC^U** /$?V8OV,_#G[.7Q.^(OBC1
M_"_@KPK<>-+R"""T\-:;%8P1Z?;*WDF?RXX_-N9)IKJ:20@D><D8+B+>W$_&
MK]A;Q!\0OAQ\9=%L=2L3!\2/'UAXL73Y=1GA@U.QAL=(M[G3;N<Q3-%'</83
MY$<<B!)$4HR%XS]244 ?&'A[_@G?X]L?$'@&XOM:\)W%YX;;0WC\1PO-'JWA
M"VT^2-Y])TR,1"&2VO8XA;SR'[,9%ED=XI,111>A_L6_LB^(OV=?%NN:AJS>
M&[2.^TRTTV8:+<W,S>*+N%Y&DUS4/.5<7\RNB/@RMM0!IY L:Q_1E% "+]VE
MHHH **** "BBB@ HHHH **** "BB@G H *P?B/\ $G1?A'X,U#Q%XCU"'2M%
MTM!)=74JLRQ*651PH).68   DDUNEP*XWX^?!31_VC/A1J_@OQ"LC:'K@BCO
M8UBAE%Q$DT<AB9)D>-HY-FQU9#E&8<$@@ R]*_:O^'^KZ'/J4?BBSCM;72[O
M6YOM,,MJ\5E:2".XN"DB*X2-V"DXZD=:U9_C]X.MM8;3Y/$FEI>1W<ED\328
M:*2.S2]DW\?*J6TL4C.V%42ID@L >!^*?["GA?Q];:+9Z%J>L_#C2M*T.[\+
M2:;X6M["VL[S2+EXGFLC%+;R+"F85VO;^5(FYMKC(Q3\:_\ !.OX>^/?%/C;
M5KY=62X^(YN+/Q*+>6.'^VM+GTJ+3)-*G98P[V@CA65,MYL4S.T<B*[HP!V'
M@O\ ;!^&OQ$TV.\T?QEH]Y!+?6^FH=S1L\]QN^S@*RAMLNQ]CXV/L;:QVMBU
M9?M3?#_4M U/58?%FDMI^C:,GB*]G+%5MM->2XC2[;(_U3-:7(#=#Y+$9')X
M'Q%_P3W\-_$ZT\OX@>(O$OQ)D>[T^69O$-OILL=W:V4TLT-C+!%:1P/ 9)G9
MR8_-?Y<OA0 SQ!_P3_TWQ#:I;M\0OB.MK>:./#6N(US97#^)='CN+F:WL+J:
M6V>4+"EW/"L\+QW#QR$R3228DH ]1^)WQ[\)_!F\TVW\2ZU#IUUK!D^Q6PAD
MGGN%C,:R2+'&K/Y:-+$K2$!%,L8)!=<X>L?M@_#GP_XL\0:+>>*K6WU#PK#<
M7&L![>;R=.2WMA=3&6;9Y2E(")"-V0I!QR*Y_P#:\_87\*_MH?V'_P )-=W]
MG_8*W$<#VMCIT\T8G\O>\,UU;32VDX\I-EQ:O#,A&5<$*1S6J_\ !-3PWJ/Q
M1^*7B>'Q9XET^3XP:=<Z7XAMX-+T4S2P3:='8!%OGL&OBL:QI*B27#H)!DJR
MDH0#U.^_:D^'NFZEJEE<>,M AO-%UK3O#M] UTHDM=1U#R?L-JR]?,G^T0^6
M/XO,&.]9</[:'PSFU'7;7_A+;-6\-S36^I2M;SK;VTD-XMC+'YQ3RV=+IA"5
M5B0^1U!QS7C3_@GQX)\=^,+CQ!?7GB+^UYM?TKQ MQ%<QQ[)--N]-NK:$H(]
MDD8DTT &57DC6^OA$\?VAJY[PI_P3%\,^#+GXCK8^+/$UOI_Q.UJ?Q#JUK#I
M6AV\GVV75CJBR&ZCT];J<12/+%&+F67;#*R\L%=0#UOXQ_M/>!?V?Y[6'QAX
MBM]#DO+>:[C\V&63;!#M\V9S&K!(TW+N=\*,\FM.#XW>%;G4/LD?B#3I+DZP
M/#XC63+&_-O]I%L.WF>1^\Q_=YKRG]M7_@G=X0_;GU#0[CQ5J5]9_P!AV=W8
M11Q:3I&H*4N3$9'0W]G<M;S#R5VS6YCD7)^;ICH++]CW3=.^-%OXLC\6>+Q8
M0ZHNO_\ ".O+:-ITNIBQ^P?:VD: W98P=8_M'E%_FV9)H [?P!\;/"OQ3E6/
MPYKVGZT\FFVNL*+63?NL[DR"WG'^Q(890#_L&N/\,?MT?"7QE!J\NG^/-%FC
MT*(SWKN7B"1"<6[2+O4;XUF98RZ;E5F4$@D5A?#?]AT?!WQ%X9N_"_Q*\?:/
M8^']$TSP_=:<+?2)X-<M;"29XOM#RV33*SB>17-O)%D$;0K#-8>C?\$VM'M_
M",^AZO\ $+XA^(M/AL;K3-*2\_LR$Z';75W#=3I";>SC\PLUO"F^?S65%.""
MS,0#UC1_VF_ /B#4KFSL?%VAW5U9:_<>%;F*.X!:WU6"!KF:S<?PRI C2$-C
MY!NZ5<^$/QZ\(_'?3KJ[\):Y:ZY:V;A))8$=5Y&592RC>C#D.N5;L37E^N?\
M$ZO WB7QO#K]Y?>))KO^T]7O]0C2XAAAUR#48KR-K&[5(AYMO!]MN&MSD2PM
M))MDQ-,).F_9T_9)L?V>O%OB+75\7>./%NJ>([>SL99=>OHGBMK>T1H[>.*&
M"**%6"-AI2AED"KO=B : /6J*** "BBB@ HHHH *,XHKS+]K+QOXL\ ?"*;4
M/!]NTFH?;[.WNKF/2I=6FTNQDG1+F[BLXB)+B2*(LXC7)R,[) I1@#TTG I%
M;=7R%X\_: ^.5IX<M9O .E6GCB ^!==U&:_US1K[PI-]OM[B".R=+5[6X>29
MXVE/DL(DFV!TVJ0HU_%?Q/\ C<\^K7.ABW46_B.Q\/6]IJ&C,D;0:AING :@
M&16=A97LMQ*R<)(GFQL\9570 ^IMU87Q2LM0U3X9^(;72;=;S5;C3;B*SMSJ
M<VF">9HF")]JA!EM\L0/-C!=,[EY KY=_P"%W_&[2?'FI:4BW^LWU@-9MKW3
M)?!%Q:V]A96MI>-INK0ZGG[+=3W=Q%9!K>,MQ>,JQ1&UG)Y?P_\ M3?'*7X/
M:Y:^'=/\6_$;Q%K&D:7;Z#J,_@(:!=:9K-Q]I:^5HKZ6TM;F&TMX?/&][="Z
MI;F>22X01@'H_P !?V??B=X%_9[O--N[B;1]6CDU2Y?P];^+)[RTU=Y[4+%!
M%J<L+7FFQ"8,P>,RRJ[O(6=CBK/[/7[-WCC2/V./'7@?7W_X1GQ)XJAU&"UE
MB\2W>O6VFO<V20B6WDGQ<1QB;?(8VED<R-+(9-TF!>UOX\?%C7_@EHNO:/X%
MM]'U2YN] L[JSO[N1]0MKY]9M[/5K.>W2V>-;>&+[21>P331NJ^;&&CV2-PW
MBO\ :A^*O@GX<7%WJ&D^)IM>O/#7B&TBMK#PA/?+:>*HKA?L5I&((W+6NQF$
M,\N(YXU#NRL650"7Q=^SG\9OB=JFM>)-:LO#NFV]Q;Z'I4O@/3O'>H+8Z]::
M>-7,[/J45I"]N9Y=2MG\M;<B>/2HHIV5+AT@Q_B_^QG\;?B-\-?'UGX:\7K\
M-[O7OA=)X6TW2K7Q-<^(HUU,RZN4+ZC>P+<Q+LN[/]]$@D7#(,K!"S?5%SJ$
MOCCPUKVBZ+KLFE^(--4:;<:@MHDSZ;=O;13!PDB^5(0DT;X&4RV#T('RW9_%
MGXW>%O@5\,M0\1>)M8BN/%.D76K:]K-O\-)M7NM)U)5LOLFC_P!G6?[Q8I6>
M^+2NN2+=8A+%)+&Q %_:6_8[^+WQ%U?Q1/X<OK.2+4_&-UK6FPS^-+O2[>T@
M?2]+MX'DABM)O,,=U:W,@"21M$'+H6DD(7I_%?[//QOUWX_:SXR'BKPS_9.K
M:%<^#SHL(O;=H+0VCM#J*R_:&@6;[?ER@M_-6&?:;A_*56K^#?C!\<O$_CF*
MU\4:3<^#]#N-1TVQO+K2M.2_NM'NKG0K.7RO+=&1K$:E-/&]VDDS(Z)&42+S
M;F+'U+XS_'C3='L;KQ%>-X;TV35;GP]J&HZ/X&NM?EM9-/\ ,C6^CM8AYPCU
M.;+C*2QP11QQ*Q>;SU &^/\ ]DCXX::FEWW@OQ%I"ZEX;TC3]?LK74-5N5MM
M0\506,6EO'=;%R^G&R$SE/X[AXY-JM'E[FD_LD_&;P/\4EU#1_%6@WG@:T\.
M/X"M]!O9+MM2DTY+-_)U:2\\[[.U\]]AG46JGR)2!*6C"/Z1\1?B9\3[7_@G
MY=>+K728])^+'_"+Q:BVFPZ:UT(-0,:-)"MMO=LY+*$+.4)P2^TYY'XY_'+X
MT>$_V@-6TOPKH,FJ+:7%G%X=\.'P[/)8^*;"2&-[R^GUO>+>PE@E^T1K#*0<
M6R924WL!C *_P:_9A^(W@+XJ>'-2\0Z=I_BJ&SL]-A&L-\1-6LI=!AATZWM[
MBS338X&MKI6N(Y)MSR()_,S+M:"(MR^@_L4_'#2? ^BVEQ\1I=8OK/P+%HS0
MOJ<FCK#<I?Z?<2V:7UG%]J5+BWM[BW-Z TT.\.BLQ(KM/V?/C=\:/%PU[;HE
MGXRTVUAL)XK_ %K1;SP/<0W<J7IO[&&UGCE-P+9HK 1L61&%XZ-<N\#L>"TO
M]IKXX7?A2-[Z35K32;B\T]=<\1Q_#+4%O?"\LMK?R7EG;Z<Q:2ZBAN8=.A6Y
M5)E5;R3<TFPRH >K_!?X(>.OAS^SA\1=)GL;2'4=>N;JZ\+^&8?&FHS6_AZW
M>PMX$L%U8HES$K7$4\^Z!!]G^U&.(D1*QPOA3^S/\5=+_9?U;PW#XIG^'OB*
MZLM=M[>&#5FUVVANKV +:7$5S-&+FWCMIB[I$CLQW$L[$C'8_"GXE_$KQ-XY
M^%*^(M+CTNSU_P (ZK?^([6/2GA$&H13:>+0EGD=K;?%+<M]F=F922I=C$2=
M[X(?$W7'@U^'QQ-Y-W<>.-3T70#_ &<]J+FT1GDM5 YW8@1@920',9(QD* #
MR30/V7?B5+HW@BUTA+7X1GP_XP?5[Q[#QQ?>,C-9G1M2M'PNHVR(N^[N()"@
M!W\S.5ERM<E<_L4?&1+'PW"VL6^JWEEH,.FVNJ2>-M2TF3PEJ*:A?SS:K';6
ML)BO7GM[BVC:)S&H%J8/]3/(5]A^,'[2_B+P7\>I--T+PSXJU[0_"OA35M0U
MNUM] N8_[3U0OI8TFTM+R5%@D,PGO5)C=D1HF,K1B)J\:TKXS?M0?$SX>>!_
M#MGHEUX)^)EEJFIV/BB;Q#I]G:V=Y'%;)<6EQ&]K_:-NL4BSQC9'*Q+Q3QF5
M'0T =9X&_8T^)7ASXL:3K%]XM>]\.V'Q(USQE_9#:G<.R17TFJQHC2L<26Z6
M\]D4M"H6.:2=@Q6.$#8_X)I_LW^-/V;_  =K&F^-M&T^WU2Z^SEM6@\2/JC:
MF5#@JT;01"/;][>2S.9""?D!/&>+/VIOCSHFL?$2S;P%X@DT^S\&ZC9>'?$-
MGHMJ=-G\4:=8R2O)!;_:Y;Y[>YN!<QQK<01QC[!;A))OM8(]4_9-^)OQ3\4?
M%+Q-X=^)&BMI_P#PC>@:.\.H6UHJ:9KUS.UV9KNU?.]=R) LMM*%:WE215\V
M)HIY0#WVBBB@ HHHH **** "@C-%% !BDVTM% ";:S/&5_JFF>&;Z?1-.MM6
MU:*(M:V=Q=_8XKB3LK2['*#_ &MC?0UJ4$9% 'QQ8?\ !4#Q%J'AWX+S1_"<
M_P!J?&[P]=>)]'M8]9NKR"RL8CI"QM=3VNGS"WWG5X]TDRQV\(A;?-\Z ^OZ
M_P#M>VFA?"3XL>)VTN.2X^%TNK1_V8NH+YVJK86PG)7Y24+C@#:V, \YQ78>
M*OV:/AWX[T;1=-USP'X-UC3_  Y;FTTFVO=&MYXM+A8(&B@5D(B0B*(%4P#Y
M:<?*,-O?V9/ASJ7BG4M<N/ 7@N?6M:BFAU"_DT6W:ZODFC\N599"FYU>/Y&#
M$[EX/% '@?B[_@I3KG@[X;^#=:_X5/K6H:IXVU&^M;72+"'6)KR.*U@$IDDM
MAI7VV-G8[ );9(URCM(JNI/47G_!0JQTSXG0^#[[P/XXL=>GUK1M'(?0[^:P
MM3J%O;3-Y^H0VTEA%+!]H*&%KC<[(,']XF?8?!'P&\$_#.*&/PWX0\+^'X[>
MXENX5T[2X;7RII(UBDD78HP[QHB,PY*HH/  K3N?AYH5[=3W$VC:3+/=7<&H
M3R-:(7EN80HAG8XR9(PB!6/*[%P1@4 ?,>I?\%/Y;7X;ZIXDMOA^U]'-X<N/
M$OANRB\1VIN=7ABO+6T,-T,8L)FDO(<*Y<+B179'1E$/B3_@JWIQT"ZOO#'@
M?6M=EM?&J>")+*1+P7UI>?V-'J<RW%K:VES<120M)Y#IY3!2N\L(R&KZ2M_@
M;X,LY]7FA\(^%XIO$$JS:HZ:5 K:DZL&5ICM_>$, P+9P0#UJOXO_9X\!_$"
M"\BU[P5X2UJ+4;X:G=I?:1;W"W-VL*P+<.&4[I1"JQ[SEMBA<X&* &ZE\7+?
MPS:>"X]7AAM=2\97/V***"Y$UO;S+93WLO[[ #(L=M-A\ ,0O SQ\\_!S_@J
MK9_&3]G[Q[XYMO 6N:>W@G0]/\1Q:=>22V;ZG:7JRM R-<01$C$+YEB26W?_
M )933;6V_45OX#TBST_1[.#3;.VL_#[(VF0P1"*.PV1F)1$%P$ C9DP,#:Q7
M&"169H?P+\%^&?#>J:/IOA'POI^DZXS/J-E;:5!%;W[-PQEC50LA/^T#0!R'
MQS_:@C^$^@^)I--\.Z]K^L>&$MI)K1]*U&V@O1.DCJMG.MI*+^4"-MT-DL\J
MDJ&12P!N? /]IW0_V@+327TV.:WN-6\*Z7XNBB<B3R[2_P#.6-2R_+O5X)58
M GH#WP.S\;_#C0/B;X>;2?$FAZ/X@TJ1@[6>I6<=U;L1T.QP5R.QQQ4VB^"M
M+\-W33:?8VME(UM#9CR8PH2"+(BB4#A8UW-A5  +$XR30!\T:S_P4DU*UM/'
M=OI?PQU37?$'@^]T>&UTZTU HFMVVH7KV@N8)I(%$J0E"\CP": !E'G;EF$3
M;;_@J-HC^._A?I,WAFX\OXD6^F"*:.XD::*ZOI)H/+@@:!7FBMIX3'=2-Y36
MXDC9DPPKWF+]F_X?6_AW5M'C\"^#8])UZ87&IV2Z-;K;ZA*.0\J!-LC \AF!
M(/-:EO\ "?PQ9ZWI>I0^'=!AU'0[7[#IMU'81+-I]OMV^5"P7,:;>-JX &1T
MH \F^&/[86K:WXW\3:/XM\"WVAQ^']9T[P\EYX>:\\413ZA=H9##(+6S#6Z0
MQM;O+/*!!%]H4/(NTFN%^%G_  5,LOBK\._B=KUIX%UJU_X5_P"'+GQ38V]U
M,]LOB&SB:Z4&&6:&-) QML^=;&XM@LT6)F8E1]2:#X6T[PM;2PZ;866GPSW4
MU[)';0+"LD\TC2S2D*!EY)'9V;JS,2<DFL72?@;X,T&TUR"Q\)>&;.'Q1O\
M[9C@TN"-=5W@A_/"J/-W L#OSG)]: /)_&_[=MKX,^*D&ACPW+=:7#J>@Z+J
M=]_:,4=U;7>LRPPV?D6F/,N(5>XB\V7*!%$I&_R9 OH_P<^,I^*?B[XD:1)I
M,NE3?#SQ,/#DC/<K,+X-IMAJ"7"A1\@:._0;"21L)/7 W=0^%_AS5?%.FZ[<
MZ#HEQKFBQ-#I^HRV,3W5@C @K%(5W(""00I Y/K6CI/ARPT*[U"XL[&SM;C5
MK@7=])#"L;WDPCCB$LA R[^7%$FYLG;&@Z*  "[1110 4444 %%%% !1110
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MDUGPI^TW8>,'U7PO#8Z7KFIZX^I66ER0^)/$*WL%U$--U"Y:0K)9P&X2554
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M** "BBB@ HHHH R?'/A^[\5>%+[3K'7-4\,W=Y"T46JZ:EM)=V#'I)$MS%-
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MT;18[6.6*?4EEM_+21C<(;*2S=]TL;E5>VO+;#!6D64(%(!]+;S_ '309/\
M9_\ K5\8ZY_P2VAO/@O?^#=%N5\)+JWCY=9NM1TN^,]RFBQ74TUM BWD-Q"S
MHDBQ^5)$T>T'G.TC!\$_\$[_ (E>$?CU\+_$>L:C:^+]*\#:)IND7,5QXE\E
M+NZM-3U*=M2:*33IG4O'=6L\=M:3VJ1/ +9FF@CBP ?=A<C^&@R8/2OB;X5_
M\$[?$6FZ/\8M)\6Z=I&KKX^_M2ZTS49/$GF-:RR7LMQ90K'#86\L<2[T=GFN
M+F1&B"H=G ]H\-? S5=!_8Z\4?#71])LO#UW%H5SHND3C4I98;V>>P3?=%R#
M+$OVR6=>=S;8A(/OA0 >XF3 _K1YO-?&=K^PG\5/ 6N>*[OPWXST^\_L/1?"
M]O\ #8:O?W<KV$^FSZPUU;:@P4B:%[?4Q;1SX:8QK&TN^6!97]4_8Y_91UK]
MG+6?$$>L>(KKQ-IMC%!H?A2>[NI)[R/2$:2Z_P!++8#7 N+J:'>,EH;6V8MO
M9P #WI3N%% XHH **** "BBB@ HHHH **** "OFK]K+Q_P#&CX?_ !8MX? =
MC>:WX=O=(_M^01:.+I;0Z4[S7>F"0#(FU9)K6W@+;C"8+J10S;$KZ5I@BXH
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M1;G26T9YY],L[72;];NYD:'3K^39-JD2")Q R/ MNP>,7!QL>,/C9^T#X?\
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MH/V7?VIM3^/OP,U+QIJ.@V>B"UC:>VLDEOHYVC6 2'S8[ZSM9HB6W*"8RCJ
MZL0: /%OB[XE_:&^%GPN^)%UH_BSQ%XJU33?'.D:+HKW'ABW@V:4T5C+>7:_
M9;"X=UW7%S&9%MIPHMQA-P=CZ;\0/B[XO\(_L+Z7X@L[KQKJGC"Z6PMY+BQ\
M*&YU6266Y2.9_L<D$(B15+DS/;@1QJ9/L\AQ"WFOP;_X*SW'Q7\--N\$V>D^
M(+P:*-/AU'4KS2;$G4ENV3[1+?V-O(D:?8Y5$L,4T4LCQQ1NSD@=7HW_  4@
MFUWQAX)T.W\*6#7WC749-(6Y375DT_3[BVU&:SNY)9_+'^CR+ XLY0F;N<K!
MMC.YU ,31_C?\>;G7_ <;6UUJ%]<0^'8Y[:V\(W%IHWB&.;R4UR^GNIU$VG/
M;YNI(+>58V/E0@B8SA8^Z_8N^)WQ3\<^*=:A\=6^K&QCTNTN+AM0\._V+_96
MK/)*+BPM3D_:K9$6)A-E^6_UK[]L>Q\8?VR(/A#^TOX'\ W&FV-Y:>,KN/3V
MOH;V9[C2YY(Y6B-Q&MNT,*2-&B1^=<1O,TC>4DGDR;=#]EK]I^X_:.U3Q1#)
MH^EV=IH-RD-M?Z7K2ZI9WX)D5U641Q@R1M&5<Q^9$&.P2,Z2*H![$IR** -H
MHH **** "BBB@ HHHH **** "J7B77(?#'AV_P!2N5N&M].MY+J400M-*412
MS;44%F; .% ))X )J[0>10!Y/H_[:/PW\0>(7TFP\0K?:E')I,36]O;R2N#J
M<$EQ9'"J?E>&*60MT58V)QBN@^$WQ\\,_&L+_P (]>7-T6T;3=? DM)+<FSU
M".1[63YP.66*3*_>4KA@,C/&> /V!OAO\+/%OAO6M%TR\M;WPN-733PMT1&J
MZC(&9708#BWB!M[8$8MH'>*/:C$4O@C]B31?AKXQ\/ZMH'BOQ[I,>@Z+I.@'
M3X-1B^Q:C:::LJ6RW"&$LQQ-)N*LI?<,\*H !#X;_P""AOPE\6^%M#UC3?$T
MUU9^(O"=_P"-K()IUR)CI=D56XEDC*!HG#,56.0*[F.4*K&-]NYI_P"V/\/=
M3\=:QX9AUR5M>T/5=/T>]LVLIDDBFOK=+BU890!H7CD7]ZI,:L'1F#HRCF]#
M_P""=/PO\,>%K?2=-TO4-/CA\-W'A9YX;QO/N[6:PM;!GD)!#2B"SB ;  8R
M-C<[$[&K?L1> ]>\;:3XCN[/4)M;T/Q(OBFQN_M162"Y%A;V#1?*!NMWAMH-
M\+95GC1_O(A4 Q==_;B^%?B7X5:SXFNK'Q=KGA3P]]GU66X/@/5KJ"X@5_.A
MU"U!M2+FW1HQ*MQ"'0!4D#;2C,SQM^U;\(=6OO#=QXHTC6&O+%%UJ*35_ NH
MO)X/A>26%;Z_=[8_V3&QAE/G7)A7RXI)"WE1R.J^"/\ @G#\,?A[IGBFUTVS
MU\+XJ\,OX,>2XUB>Y?3=%*%%L;<R,=L<>6*,X>1053?Y:1HG1?%']CCP?\7O
M$;:AJS^)(X]0L(M)UNQLM8N+.R\2V<1D,5O?0QL%E0-*^<;3(C-%(7A9HF ,
M_P"&/[0OPA\6?$W4V\-?V<OBZ_\ $]WX)U&5-$>UOKG4+*.\FDCF=HU=X0MC
M>%)B3$YA<(S'BM[XN_%?P7^S+X*T#3]2TG4/[+UR\_X1_2M'T#P[/JC3R?9;
MBY,"6EK$[!!;VT[GY-H$9!Z@'&MOV(/ ^D^-=!\4:?;:A:^)O"^I:YJNG:BM
MR?,$NKRWL]RDHP!-$LU_</$C@^46^4C+;MCXJ_LV6WQA\,>#K/4O%/BZRU?P
M3>KJ=AKFFW,%MJ#W7V&XL7FD_<F(F2&[N RB,*#)E0I5< '#^"OVI/@O:>,?
M!_A#PGI-U->S6L5UI5OHO@N[\G04NKBZLV6?R[<#3Y%GL[R*>*8120M;S+,J
M%& ])\7:WX+T?QE9^"]7L;&34/B<MZ6LWTTS0:VMO;1I<?:6V&-OW'EQ[93E
MT7: 54A?/=*_X)T> ?"OQ8\/^,M N?$_A_5_#UM#:JUO?)<M?(EY>7LAGGN8
MY;AY+B?4+QIY!*LD_P!H?>S'!'K'B?X7Z;XL\=^%_$5U]J_M#PC+<RV CDVQ
M[IX3#)O7'S?(3CD8/- 'BEU^US\ ]4;7O%4]K#/J&BVUKIKW4O@V[_M#5K.]
MN#9VPL@UMYM[:33YB5X-\)P22$.ZI?A'^T5^S[X/OM#\.^![+2- M/'T5K=1
MG2_"$^G::[W(>*UAO95MTAMKF;R9(HX+HI*S*(]NYT5FR_\ !+7X1S:9XLA;
M2M3^V>,+^'4+B^:\WW%J\$TEQ"D08&,Q)--+(4E202%\2B0*@72T[_@FY\*=
M-\6> ]9_L?4+B;X;Q*NC0W6H23PK*EQ)<PSR;R6=XIY99$&X1JS@[,QQ>6 ,
M^ 'C/X!?$#PWKWAGP9X?\+:3H]X+;[;I4_A3^Q+77(+@O';7$<,\$27EO,8I
M%CF0/&YC8*QQ68O[5/P!U+1+AH=,6\BEBTVUTRTB\"WLD_BFWBDDFL&TJ 6N
M_4[:%UEG22T66*%%:XW)$?-/5?"#]@?X7?!77==U33?#-OJ&I:]J,&I2W&K(
MMZUN]O+-+;"$.N(_)DN)V1P/,W2LS.QYK+T__@G1\.M'T^WALY/&%K=:,L,?
MAF]3Q%=&Y\&0PAUBATQF<B")1+*C(0PEBD\B7S+=4A4 M6G[2?P<\8_%GP%=
M"W^T^*/%$=Q9>'=9N?"5XC0RCSA<:>UY);@6MVAM9TFM)72:)X&CEC1]JG0_
M9B\1?"76/$OBJU^'/A>S\+ZM8- -9C'@^;P[<7:/YA@FQ-;PO/"Q$VR50R$A
ML'G)S]/_ ."??PZTKQIX/UJ&'Q(TG@>:2\TZVN-=NKJ%KR29YY+QS,[R&>2:
M2225U<?:7<-.)F2,IT?[._[+^F_LVRZX=,\1>,-<37KC[5,FN7R7ACE+N[.)
M!&LCNQ?!>5G;"*,X6@#T\44*VX44 %%%% !1110 4444 %%%% !1110!D^.?
M!&B_$GPK?:#XCTG3->T'5H&MK[3M1M4NK2]B;AHY8I 4=3W5@0:^%?&/_!&+
M1X/AG\(-%T/P+\$=1A^'JZM-JFC7VBP66D:O>7KV)%R4%E.&;R[)87)C5V1@
M X"X/Z 48H ^8_$7[,?Q"U30?C1X-AM_AU_PAWQ8_MFX%[)<7/\ :$<U[8+;
MJ)8?(,3J'50S;R2@^Z2-M>5Z#_P1TT/Q?\'?AWX%\6>%?AGHGAOP/K]]K<UM
MX?L;6=M2>>Q>W25A)I\40F#R %A%O"0Q8<LN:^\,48H ^1I_^"9UQ:>-_$&J
M:=XWUNUTV]^(7A;Q;8:-)>23V+6ND6>@6Q2[\P-+<7;#1Y"LQDZO"6W%6W<9
MK'_!)O6/$WPD\9>$;R;P"DGB#P[>>']1U^&UG&J_$)KB2'_3=>; $EPB1LV5
M+GS96:-K>/,+?=E&* /@OX]_\$FM?^+GA_6-+O\ 4_"/CC36\;:?K^FQ^)8!
M]HGTZUT6ZT^*"\E>VN8YKB%[D*DQA)>&"/S"9B\K_45_\*M8?P_\+;73X=#\
M/VO@Z_CN-1T;2LQZ8\"Z;=VT=O NU/W4-Q-;3("JX%L" &5*]2Q1B@#X>\(_
M\$R/$&A^"?%5I=:=\++JP\1>*+7Q)=>!YXI[CPQK<B6L]O/]I/DJVV1I+><)
M+#<D362O(\S2;HNC\!?L$^*_!_Q\^%_B34/^$)U_3OA[HR6":AYMU;:S ["X
M$T$3NDKM9(DL<4-O]HB5E7-R;EUB:/Z^Q10!\[_'3]DC7/C=^Q9!\-[[5H+K
M4/M-G<WMO<W$D-EJ]M#>K<-IEQ)&K2"W>%?(+(I)"@E64LC>7^#_ /@EQ>>'
M?V@/A'X_G7P+<>)/ .D:?H]SKS6C2WEI9V;7A2QL[=HC$%,5V8/M.Z*4*OF;
M2YQ7VQ1B@#Y$_8J_X)HQ_LGS^(K?29M+\$:+J.JV&I1VGA*9A/J<EM).[O>W
M,\7FR).LJ(T!+A1$6$FZ1S4'AG_@GW\4-*\2_$[4KSXK>#[S4/B9::);ZEJ/
M_"$SQ2ZBME/J#3Q7<:ZB-R2V]U#;@PR1;(H=H5<9;["HQ0!\U?!C]B35OAQX
M._9TT^^UC19=0^"?@V?PI=7NG6LMJLPDT^VM UK$S.J &V1LODX7C:&9:F_8
MH_8VU7]F;Q9KFI7TGA.U34--M-,E7P_;S0GQ)<0/(SZSJ/F?>U"8.%=LNV%^
1:60; GT?10 U/NTZBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>header.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 header.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $AI;G-P971E
M<BP@36EC:&5L;&4   60 P "    %   $*R0!  "    %   $,"2D0 "
M S4W  "2D@ "     S4W  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@
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M!5R2<G]:I^%9[[3IHK+6K6:XDN(E:#54@($R@#]W*O\ RR=?3A3U&#D5U]%
M'-Z>7_X61K3&&=8VL+1$E:)A&[*TQ8!L8)&]>_>LF'3;ZPDO/$'A6"0W$EW.
MU]IDJM$M^OF'#KNQMEVXPW1A@-V([JB@#B]4$R>"?#H>UNA(EW8220K SR1!
M9$9MRJ#C: <_2M.]L#JGBG1=3LD:,6)E,\[*4,D;H5\KGD@OM;T&RNAHH J:
M;J46J022P)-&(II(&69"IW(Q4_4<<'N*R/%MC<".SUO3+=[F^TN0OY$8RUS
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M@#@-<L=3U'Q+XEM]-B9A<:7;0^7/ RQ78#3>9$)2,*Q5P,\X+ ]JN>*)C?\
MPU'V"QO86:2U5+5K9VFBVS1D@H 2=H4\\CCJ:[.B@#E]!CN;+Q7JHU*V9YK_
M ,N6#48HB(YHE!"QL/X'3)Z_>!!'<"CH\(G\.^)H;RPOGBFU.Y;REB:.22-B
M,-'G!/'((]*[:B@#EM*L]56ZN8AJ4M]:R6A6"]N[98YX'S@*2%7>._W001WS
MQ)X>F-OX3M=+UC3IENX+<07%OY)D6=@,,P;&UE;DY)[\\YKI:* .'_X1M!X1
M\/>']?2:Y*38+Q[V-N0CF,B1>5*94!LCD"KNB)KUOXECL=<C:[BM;63R-64
M+<*S)A74?=E&WG'##D8Y ZNB@#)\5!G\'ZPD<<DKO8S(B1H69F*$  #DDDTS
MP_?(=)T^S,5P)8[./S-\#J$(4 @D@#.>W7BMFB@#D_!=Z+708[6>WO$GDOKI
MA&]K(I"M<2,K'(P 5(.3ZU5CTA=<\1>+;"]2XCL;R2!7W0%5N$$*JP5R,=1C
/(KMJ*  #  '04444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
